{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T03:35:28Z","timestamp":1794713728518,"version":"4.9.1"},"reference-count":300,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"DOI":"10.1038\/s41582-023-00777-3","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T09:02:51Z","timestamp":1677661371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Pain-resolving immune mechanisms in neuropathic pain"],"prefix":"10.1038","author":[{"given":"Nathan T.","family":"Fiore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie R.","family":"Debs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica P.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel S.","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3828-9527","authenticated-orcid":false,"given":"Gila","family":"Moalem-Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,1]]},"reference":[{"key":"777_CR1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jneuroim.2010.08.013","volume":"229","author":"PJ Austin","year":"2010","unstructured":"Austin, P. J. & Moalem-Taylor, G. The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines. J. Neuroimmunol. 229, 26\u201350 (2010).","journal-title":"J. Neuroimmunol."},{"key":"777_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nri3621","volume":"14","author":"PM Grace","year":"2014","unstructured":"Grace, P. M., Hutchinson, M. R., Maier, S. F. & Watkins, L. R. Pathological pain and the neuroimmune interface. Nat. Rev. Immunol. 14, 217\u2013231 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"777_CR3","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.brainresrev.2005.11.004","volume":"51","author":"G Moalem","year":"2006","unstructured":"Moalem, G. & Tracey, D. J. Immune and inflammatory mechanisms in neuropathic pain. Brain Res. Rev. 51, 240\u2013264 (2006).","journal-title":"Brain Res. Rev."},{"key":"777_CR4","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1152\/physrev.00011.2002","volume":"82","author":"LR Watkins","year":"2002","unstructured":"Watkins, L. R. & Maier, S. F. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol. Rev. 82, 981\u20131011 (2002).","journal-title":"Physiol. Rev."},{"key":"777_CR5","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/nm.2231","volume":"16","author":"R Kuner","year":"2010","unstructured":"Kuner, R. Central mechanisms of pathological pain. Nat. Med. 16, 1258\u20131266 (2010).","journal-title":"Nat. Med."},{"key":"777_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41583-020-0310-6","volume":"21","author":"JS Mogil","year":"2020","unstructured":"Mogil, J. S. Qualitative sex differences in pain processing: emerging evidence of a biased literature. Nat. Rev. Neurosci. 21, 353\u2013365 (2020).","journal-title":"Nat. Rev. Neurosci."},{"key":"777_CR7","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/S0140-6736(21)00393-7","volume":"397","author":"SP Cohen","year":"2021","unstructured":"Cohen, S. P., Vase, L. & Hooten, W. M. Chronic pain: an update on burden, best practices, and new advances. Lancet 397, 2082\u20132097 (2021).","journal-title":"Lancet"},{"key":"777_CR8","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1097\/j.pain.0000000000001939","volume":"161","author":"SN Raja","year":"2020","unstructured":"Raja, S. N. et al. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain 161, 1976\u20131982 (2020).","journal-title":"Pain"},{"key":"777_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.pain.2008.01.006","volume":"138","author":"N Attal","year":"2008","unstructured":"Attal, N. et al. Neuropathic pain: are there distinct subtypes depending on the aetiology or anatomical lesion? Pain 138, 343\u2013353 (2008).","journal-title":"Pain"},{"key":"777_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1152\/physrev.00045.2019","volume":"101","author":"NB Finnerup","year":"2021","unstructured":"Finnerup, N. B., Kuner, R. & Jensen, T. S. Neuropathic pain: from mechanisms to treatment. Physiol. Rev. 101, 259\u2013301 (2021).","journal-title":"Physiol. Rev."},{"key":"777_CR11","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","volume":"155","author":"O van Hecke","year":"2014","unstructured":"van Hecke, O., Austin, S. K., Khan, R. A., Smith, B. H. & Torrance, N. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain 155, 654\u2013662 (2014).","journal-title":"Pain"},{"key":"777_CR12","doi-asserted-by":"publisher","first-page":"17002","DOI":"10.1038\/nrdp.2017.2","volume":"3","author":"L Colloca","year":"2017","unstructured":"Colloca, L. et al. Neuropathic pain. Nat. Rev. Dis. Prim. 3, 17002 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"Suppl. 1","key":"777_CR13","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1111\/j.1526-4637.2004.04019.x","volume":"5","author":"B Nicholson","year":"2004","unstructured":"Nicholson, B. & Verma, S. Comorbidities in chronic neuropathic pain. Pain Med. 5 (Suppl. 1), S9\u2013S27 (2004).","journal-title":"Pain Med."},{"key":"777_CR14","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.pain.2010.02.034","volume":"149","author":"AH Doth","year":"2010","unstructured":"Doth, A. H., Hansson, P. T., Jensen, M. P. & Taylor, R. S. The burden of neuropathic pain: a systematic review and meta-analysis of health utilities. Pain 149, 338\u2013344 (2010).","journal-title":"Pain"},{"key":"777_CR15","doi-asserted-by":"publisher","first-page":"l959","DOI":"10.1136\/bmj.l959","volume":"364","author":"O Dyer","year":"2019","unstructured":"Dyer, O. US opioid epidemic: FDA demands studies of whether opioids do control chronic pain. BMJ 364, l959 (2019).","journal-title":"BMJ"},{"key":"777_CR16","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1097\/j.pain.0000000000000154","volume":"156","author":"MO Martel","year":"2015","unstructured":"Martel, M. O. et al. Self-reports of medication side effects and pain-related activity interference in patients with chronic pain: a longitudinal cohort study. Pain 156, 1092\u20131100 (2015).","journal-title":"Pain"},{"key":"777_CR17","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.it.2015.08.006","volume":"36","author":"A Louveau","year":"2015","unstructured":"Louveau, A., Harris, T. H. & Kipnis, J. Revisiting the mechanisms of CNS immune privilege. Trends Immunol. 36, 569\u2013577 (2015).","journal-title":"Trends Immunol."},{"key":"777_CR18","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/s41590-021-00994-2","volume":"22","author":"T Croese","year":"2021","unstructured":"Croese, T., Castellani, G. & Schwartz, M. Immune cell compartmentalization for brain surveillance and protection. Nat. Immunol. 22, 1083\u20131092 (2021).","journal-title":"Nat. Immunol."},{"key":"777_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/bja\/aet128","volume":"111","author":"A Ellis","year":"2013","unstructured":"Ellis, A. & Bennett, D. L. Neuroinflammation and the generation of neuropathic pain. Br. J. Anaesth. 111, 26\u201337 (2013).","journal-title":"Br. J. Anaesth."},{"key":"777_CR20","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1016\/j.pain.2012.06.005","volume":"153","author":"PJ Austin","year":"2012","unstructured":"Austin, P. J., Kim, C. F., Perera, C. J. & Moalem-Taylor, G. Regulatory T cells attenuate neuropathic pain following peripheral nerve injury and experimental autoimmune neuritis. Pain 153, 1916\u20131931 (2012).","journal-title":"Pain"},{"key":"777_CR21","doi-asserted-by":"publisher","first-page":"26482","DOI":"10.1073\/pnas.2006065117","volume":"117","author":"RR Bonomo","year":"2020","unstructured":"Bonomo, R. R. et al. Fecal transplantation and butyrate improve neuropathic pain, modify immune cell profile, and gene expression in the PNS of obese mice. Proc. Natl Acad. Sci. USA 117, 26482\u201326493 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"777_CR22","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1097\/j.pain.0000000000001879","volume":"161","author":"M Davoli-Ferreira","year":"2020","unstructured":"Davoli-Ferreira, M. et al. Regulatory T cells counteract neuropathic pain through inhibition of the Th1 response at the site of peripheral nerve injury. Pain 161, 1730\u20131743 (2020).","journal-title":"Pain"},{"key":"777_CR23","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1523\/JNEUROSCI.1815-18.2019","volume":"39","author":"SS Duffy","year":"2019","unstructured":"Duffy, S. S. et al. Regulatory T cells and their derived cytokine, interleukin-35, reduce pain in experimental autoimmune encephalomyelitis. J. Neurosci. 39, 2326\u20132346 (2019).","journal-title":"J. Neurosci."},{"key":"777_CR24","doi-asserted-by":"publisher","first-page":"17045","DOI":"10.1073\/pnas.1902091116","volume":"116","author":"R Fischer","year":"2019","unstructured":"Fischer, R. et al. TNFR2 promotes Treg-mediated recovery from neuropathic pain across sexes. Proc. Natl Acad. Sci. USA 116, 17045\u201317050 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"777_CR25","doi-asserted-by":"publisher","first-page":"69056","DOI":"10.7554\/eLife.69056","volume":"10","author":"JA Kuhn","year":"2021","unstructured":"Kuhn, J. A. et al. Regulatory T-cells inhibit microglia-induced pain hypersensitivity in female mice. eLife 10, 69056 (2021).","journal-title":"eLife"},{"key":"777_CR26","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.neuron.2021.02.018","volume":"109","author":"JK Niehaus","year":"2021","unstructured":"Niehaus, J. K., Taylor-Blake, B., Loo, L., Simon, J. M. & Zylka, M. J. Spinal macrophages resolve nociceptive hypersensitivity after peripheral injury. Neuron 109, 1274\u20131282.e6 (2021).","journal-title":"Neuron"},{"key":"777_CR27","doi-asserted-by":"publisher","first-page":"154194","DOI":"10.1172\/jci.insight.154194","volume":"7","author":"SK Singh","year":"2022","unstructured":"Singh, S. K. et al. CD8+ T cell-derived IL-13 increases macrophage IL-10 to resolve neuropathic pain. JCI Insight 7, 154194 (2022).","journal-title":"JCI Insight"},{"key":"777_CR28","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1126\/science.abf6805","volume":"376","author":"K Kohno","year":"2022","unstructured":"Kohno, K. et al. A spinal microglia population involved in remitting and relapsing neuropathic pain. Science 376, 86\u201390 (2022).","journal-title":"Science"},{"key":"777_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010902.pub2","author":"RA Moore","year":"2015","unstructured":"Moore, R. A., Chi, C. C., Wiffen, P. J., Derry, S. & Rice, A. S. Oral nonsteroidal anti-inflammatory drugs for neuropathic pain. Cochrane Database Syst. Rev. https:\/\/doi.org\/10.1002\/14651858.CD010902.pub2 (2015).","journal-title":"Cochrane Database Syst. Rev."},{"key":"777_CR30","doi-asserted-by":"publisher","first-page":"eabj9954","DOI":"10.1126\/scitranslmed.abj9954","volume":"14","author":"M Parisien","year":"2022","unstructured":"Parisien, M. et al. Acute inflammatory response via neutrophil activation protects against the development of chronic pain. Sci. Transl. Med. 14, eabj9954 (2022).","journal-title":"Sci. Transl. Med."},{"key":"777_CR31","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.pain.2004.08.029","volume":"112","author":"A Brack","year":"2004","unstructured":"Brack, A. et al. Control of inflammatory pain by chemokine-mediated recruitment of opioid-containing polymorphonuclear cells. Pain 112, 229\u2013238 (2004).","journal-title":"Pain"},{"key":"777_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000362","volume":"5","author":"HL Rittner","year":"2009","unstructured":"Rittner, H. L. et al. Mycobacteria attenuate nociceptive responses by formyl peptide receptor triggered opioid peptide release from neutrophils. PLoS Pathog. 5, e1000362 (2009).","journal-title":"PLoS Pathog."},{"key":"777_CR33","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.cell.2018.12.022","volume":"176","author":"AJ Davies","year":"2019","unstructured":"Davies, A. J. et al. Natural killer cells degenerate intact sensory afferents following nerve injury. Cell 176, 716\u2013728.e18 (2019).","journal-title":"Cell"},{"key":"777_CR34","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0008-17.2017","author":"W Xie","year":"2017","unstructured":"Xie, W., Strong, J. A. & Zhang, J. M. Active nerve regeneration with failed target reinnervation drives persistent neuropathic pain. eNeuro https:\/\/doi.org\/10.1523\/ENEURO.0008-17.2017 (2017).","journal-title":"eNeuro"},{"key":"777_CR35","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/1472-6882-14-316","volume":"14","author":"YH Gao","year":"2014","unstructured":"Gao, Y. H. et al. NK cells mediate the cumulative analgesic effect of electroacupuncture in a rat model of neuropathic pain. BMC Complement. Altern. Med. 14, 316 (2014).","journal-title":"BMC Complement. Altern. Med."},{"key":"777_CR36","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1097\/j.pain.0000000000002274","volume":"162","author":"J Lassen","year":"2021","unstructured":"Lassen, J. et al. Protective role of natural killer cells in neuropathic pain conditions. Pain 162, 2366\u20132375 (2021).","journal-title":"Pain"},{"key":"777_CR37","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41577-021-00540-z","volume":"21","author":"S Davidson","year":"2021","unstructured":"Davidson, S. et al. Fibroblasts as immune regulators in infection, inflammation and cancer. Nat. Rev. Immunol. 21, 704\u2013717 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"777_CR38","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1523\/JNEUROSCI.2132-21.2022","volume":"42","author":"S Zhang","year":"2022","unstructured":"Zhang, S. et al. Fibroblastic SMOC2 suppresses mechanical nociception by inhibiting coupled activation of primary sensory neurons. J. Neurosci. 42, 4069\u20134086 (2022).","journal-title":"J. Neurosci."},{"key":"777_CR39","doi-asserted-by":"publisher","first-page":"13882","DOI":"10.1523\/JNEUROSCI.2524-13.2013","volume":"33","author":"C Soderblom","year":"2013","unstructured":"Soderblom, C. et al. Perivascular fibroblasts form the fibrotic scar after contusive spinal cord injury. J. Neurosci. 33, 13882\u201313887 (2013).","journal-title":"J. Neurosci."},{"key":"777_CR40","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.bbrc.2020.02.032","volume":"525","author":"D Kobayashi","year":"2020","unstructured":"Kobayashi, D., Kiguchi, N., Saika, F., Kishioka, S. & Matsuzaki, S. Insufficient efferocytosis by M2-like macrophages as a possible mechanism of neuropathic pain induced by nerve injury. Biochem. Biophys. Res. Commun. 525, 216\u2013223 (2020).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"777_CR41","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1213\/ANE.0b013e31821b220c","volume":"113","author":"Y Takahashi","year":"2011","unstructured":"Takahashi, Y., Hasegawa-Moriyama, M., Sakurai, T. & Inada, E. The macrophage-mediated effects of the peroxisome proliferator-activated receptor-\u03b3 agonist rosiglitazone attenuate tactile allodynia in the early phase of neuropathic pain development. Anesth. Analg. 113, 398\u2013404 (2011).","journal-title":"Anesth. Analg."},{"key":"777_CR42","doi-asserted-by":"publisher","first-page":"133093","DOI":"10.1172\/jci.insight.133093","volume":"5","author":"MO Celik","year":"2020","unstructured":"Celik, M. O., Labuz, D., Keye, J., Glauben, R. & Machelska, H. IL-4 induces M2 macrophages to produce sustained analgesia via opioids. JCI Insight 5, 133093 (2020).","journal-title":"JCI Insight"},{"key":"777_CR43","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1097\/j.pain.0000000000000097","volume":"156","author":"N Kiguchi","year":"2015","unstructured":"Kiguchi, N. et al. Peripheral interleukin-4 ameliorates inflammatory macrophage-dependent neuropathic pain. Pain 156, 684\u2013693 (2015).","journal-title":"Pain"},{"key":"777_CR44","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1523\/JNEUROSCI.3040-20.2021","volume":"41","author":"D Labuz","year":"2021","unstructured":"Labuz, D., Celik, M. O., Seitz, V. & Machelska, H. Interleukin-4 induces the release of opioid peptides from M1 macrophages in pathological pain. J. Neurosci. 41, 2870\u20132882 (2021).","journal-title":"J. Neurosci."},{"key":"777_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0735-z","volume":"13","author":"M Pannell","year":"2016","unstructured":"Pannell, M. et al. Adoptive transfer of M2 macrophages reduces neuropathic pain via opioid peptides. J. Neuroinflammation 13, 262 (2016).","journal-title":"J. Neuroinflammation"},{"key":"777_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02283-z","volume":"18","author":"H Iwai","year":"2021","unstructured":"Iwai, H. et al. Tissue-resident M2 macrophages directly contact primary sensory neurons in the sensory ganglia after nerve injury. J. Neuroinflammation 18, 227 (2021).","journal-title":"J. Neuroinflammation"},{"key":"777_CR47","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1097\/ALN.0000000000003241","volume":"132","author":"R Tonello","year":"2020","unstructured":"Tonello, R. et al. Local sympathectomy promotes anti-inflammatory responses and relief of paclitaxel-induced mechanical and cold allodynia in mice. Anesthesiology 132, 1540\u20131553 (2020).","journal-title":"Anesthesiology"},{"key":"777_CR48","doi-asserted-by":"publisher","first-page":"670646","DOI":"10.3389\/fimmu.2021.670646","volume":"12","author":"F Kong","year":"2021","unstructured":"Kong, F. et al. PD-L1 improves motor function and alleviates neuropathic pain in male mice after spinal cord injury by inhibiting MAPK pathway. Front. Immunol. 12, 670646 (2021).","journal-title":"Front. Immunol."},{"key":"777_CR49","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.neuron.2021.11.020","volume":"110","author":"M van der Vlist","year":"2022","unstructured":"van der Vlist, M. et al. Macrophages transfer mitochondria to sensory neurons to resolve inflammatory pain. Neuron 110, 613\u2013626.e9 (2022).","journal-title":"Neuron"},{"key":"777_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12990-015-0057-7","volume":"11","author":"TK Lim","year":"2015","unstructured":"Lim, T. K., Rone, M. B., Lee, S., Antel, J. P. & Zhang, J. Mitochondrial and bioenergetic dysfunction in trauma-induced painful peripheral neuropathy. Mol. Pain 11, 58 (2015).","journal-title":"Mol. Pain"},{"key":"777_CR51","doi-asserted-by":"publisher","first-page":"6848","DOI":"10.1523\/JNEUROSCI.3257-18.2019","volume":"39","author":"X Luo","year":"2019","unstructured":"Luo, X. et al. Macrophage Toll-like receptor 9 contributes to chemotherapy-induced neuropathic pain in male mice. J. Neurosci. 39, 6848\u20136864 (2019).","journal-title":"J. Neurosci."},{"key":"777_CR52","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1016\/j.neuron.2021.06.015","volume":"109","author":"X Luo","year":"2021","unstructured":"Luo, X. et al. IL-23\/IL-17A\/TRPV1 axis produces mechanical pain via macrophage-sensory neuron crosstalk in female mice. Neuron 109, 2691\u20132706.e5 (2021).","journal-title":"Neuron"},{"key":"777_CR53","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3389\/fphar.2020.00925","volume":"11","author":"F Saika","year":"2020","unstructured":"Saika, F. et al. Chemogenetic regulation of CX3CR1-expressing microglia using Gi-DREADD exerts sex-dependent anti-allodynic effects in mouse models of neuropathic pain. Front. Pharmacol. 11, 925 (2020).","journal-title":"Front. Pharmacol."},{"key":"777_CR54","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/nn.4053","volume":"18","author":"RE Sorge","year":"2015","unstructured":"Sorge, R. E. et al. Different immune cells mediate mechanical pain hypersensitivity in male and female mice. Nat. Neurosci. 18, 1081\u20131083 (2015).","journal-title":"Nat. Neurosci."},{"key":"777_CR55","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.3892\/mmr.2015.3735","volume":"12","author":"JS Sun","year":"2015","unstructured":"Sun, J. S. et al. Minocycline attenuates pain by inhibiting spinal microglia activation in diabetic rats. Mol. Med. Rep. 12, 2677\u20132682 (2015).","journal-title":"Mol. Med. Rep."},{"key":"777_CR56","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/glia.24133","volume":"70","author":"NT Fiore","year":"2022","unstructured":"Fiore, N. T. et al. Sex-specific transcriptome of spinal microglia in neuropathic pain due to peripheral nerve injury. Glia 70, 675\u2013696 (2022).","journal-title":"Glia"},{"key":"777_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28473-8","volume":"13","author":"S Tansley","year":"2022","unstructured":"Tansley, S. et al. Single-cell RNA sequencing reveals time- and sex-specific responses of spinal cord microglia to peripheral nerve injury and links ApoE to neuropathic pain. Nat. Commun. 13, 843 (2022).","journal-title":"Nat. Commun."},{"key":"777_CR58","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.pain.2013.10.027","volume":"155","author":"V Vacca","year":"2014","unstructured":"Vacca, V. et al. Higher pain perception and lack of recovery from neuropathic pain in females: a behavioural, immunohistochemical, and proteomic investigation on sex-related differences in mice. Pain 155, 388\u2013402 (2014).","journal-title":"Pain"},{"key":"777_CR59","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1097\/ALN.0b013e318167af74","volume":"108","author":"A Romero-Sandoval","year":"2008","unstructured":"Romero-Sandoval, A., Nutile-McMenemy, N. & DeLeo, J. A. Spinal microglial and perivascular cell cannabinoid receptor type 2 activation reduces behavioral hypersensitivity without tolerance after peripheral nerve injury. Anesthesiology 108, 722\u2013734 (2008).","journal-title":"Anesthesiology"},{"key":"777_CR60","doi-asserted-by":"publisher","DOI":"10.1177\/1744806918781733","volume":"14","author":"W Huo","year":"2018","unstructured":"Huo, W. et al. Dehydrocorydaline attenuates bone cancer pain by shifting microglial M1\/M2 polarization toward the M2 phenotype. Mol. Pain 14, 1744806918781733 (2018).","journal-title":"Mol. Pain"},{"key":"777_CR61","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.bbi.2014.06.015","volume":"42","author":"NN Burke","year":"2014","unstructured":"Burke, N. N., Kerr, D. M., Moriarty, O., Finn, D. P. & Roche, M. Minocycline modulates neuropathic pain behaviour and cortical M1-M2 microglial gene expression in a rat model of depression. Brain Behav. Immun. 42, 147\u2013156 (2014).","journal-title":"Brain Behav. Immun."},{"key":"777_CR62","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.3233\/JAD-200099","volume":"76","author":"J Jin","year":"2020","unstructured":"Jin, J. et al. M2-Like microglia polarization attenuates neuropathic pain associated with Alzheimer\u2019s disease. J. Alzheimers Dis. 76, 1255\u20131265 (2020).","journal-title":"J. Alzheimers Dis."},{"key":"777_CR63","doi-asserted-by":"publisher","first-page":"108555","DOI":"10.1016\/j.neuropharm.2021.108555","volume":"190","author":"SS Duffy","year":"2021","unstructured":"Duffy, S. S., Hayes, J. P., Fiore, N. T. & Moalem-Taylor, G. The cannabinoid system and microglia in health and disease. Neuropharmacology 190, 108555 (2021).","journal-title":"Neuropharmacology"},{"key":"777_CR64","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jpain.2018.10.007","volume":"20","author":"J Wu","year":"2019","unstructured":"Wu, J., Hocevar, M., Bie, B., Foss, J. F. & Naguib, M. Cannabinoid type 2 receptor system modulates paclitaxel-induced microglial dysregulation and central sensitization in rats. J. Pain 20, 501\u2013514 (2019).","journal-title":"J. Pain"},{"key":"777_CR65","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.neuroscience.2019.08.041","volume":"418","author":"RS Dos Santos","year":"2019","unstructured":"Dos Santos, R. S. et al. Involvement of spinal cannabinoid CB2 receptors in exercise-induced antinociception. Neuroscience 418, 177\u2013188 (2019).","journal-title":"Neuroscience"},{"key":"777_CR66","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1124\/mol.116.107102","volume":"91","author":"HY Wu","year":"2017","unstructured":"Wu, H. Y., Mao, X. F., Fan, H. & Wang, Y. X. p38\u03b2 mitogen-activated protein kinase signaling mediates exenatide-stimulated microglial \u03b2-endorphin expression. Mol. Pharmacol. 91, 451\u2013463 (2017).","journal-title":"Mol. Pharmacol."},{"key":"777_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/srep45056","volume":"7","author":"TF Li","year":"2017","unstructured":"Li, T. F., Wu, H. Y., Wang, Y. R., Li, X. Y. & Wang, Y. X. Molecular signaling underlying bulleyaconitine A (BAA)-induced microglial expression of prodynorphin. Sci. Rep. 7, 45056 (2017).","journal-title":"Sci. Rep."},{"key":"777_CR68","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.bbi.2018.06.015","volume":"73","author":"HY Wu","year":"2018","unstructured":"Wu, H. Y. et al. Spinal interleukin-10 produces antinociception in neuropathy through microglial \u03b2-endorphin expression, separated from antineuroinflammation. Brain Behav. Immun. 73, 504\u2013519 (2018).","journal-title":"Brain Behav. Immun."},{"key":"777_CR69","doi-asserted-by":"publisher","first-page":"11701","DOI":"10.1523\/JNEUROSCI.1799-17.2017","volume":"37","author":"HY Wu","year":"2017","unstructured":"Wu, H. Y., Tang, X. Q., Mao, X. F. & Wang, Y. X. Autocrine interleukin-10 mediates glucagon-like peptide-1 receptor-induced spinal microglial \u03b2-endorphin expression. J. Neurosci. 37, 11701\u201311714 (2017).","journal-title":"J. Neurosci."},{"key":"777_CR70","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.bbrc.2020.05.080","volume":"530","author":"X Tang","year":"2020","unstructured":"Tang, X., Wu, H., Mao, X., Li, X. & Wang, Y. The GLP-1 receptor herbal agonist morroniside attenuates neuropathic pain via spinal microglial expression of IL-10 and \u03b2-endorphin. Biochem. Biophys. Res. Commun. 530, 494\u2013499 (2020).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"777_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1616-z","volume":"17","author":"E Apryani","year":"2020","unstructured":"Apryani, E. et al. The spinal microglial IL-10\/\u03b2-endorphin pathway accounts for cinobufagin-induced mechanical antiallodynia in bone cancer pain following activation of \u03b17-nicotinic acetylcholine receptors. J. Neuroinflammation 17, 75 (2020).","journal-title":"J. Neuroinflammation"},{"key":"777_CR72","doi-asserted-by":"publisher","first-page":"109898","DOI":"10.1016\/j.biopha.2020.109898","volume":"125","author":"U Ali","year":"2020","unstructured":"Ali, U. et al. Low frequency electroacupuncture alleviates neuropathic pain by activation of spinal microglial IL-10\/\u03b2-endorphin pathway. Biomed. Pharmacother. 125, 109898 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"777_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1457-9","volume":"16","author":"XF Mao","year":"2019","unstructured":"Mao, X. F. et al. Activation of GPR40 produces mechanical antiallodynia via the spinal glial interleukin-10\/\u03b2-endorphin pathway. J. Neuroinflammation 16, 84 (2019).","journal-title":"J. Neuroinflammation"},{"key":"777_CR74","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/cns.13694","volume":"27","author":"L Ma","year":"2021","unstructured":"Ma, L. et al. Spinal microglial \u03b2-endorphin signaling mediates IL-10 and exenatide-induced inhibition of synaptic plasticity in neuropathic pain. CNS Neurosci. Ther. 27, 1157\u20131172 (2021).","journal-title":"CNS Neurosci. Ther."},{"key":"777_CR75","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1111\/bph.15471","volume":"178","author":"RM Shoaib","year":"2021","unstructured":"Shoaib, R. M., Ahmad, K. A. & Wang, Y. X. Protopanaxadiol alleviates neuropathic pain by spinal microglial dynorphin A expression following glucocorticoid receptor activation. Br. J. Pharmacol. 178, 2976\u20132997 (2021).","journal-title":"Br. J. Pharmacol."},{"key":"777_CR76","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1002\/glia.23340","volume":"66","author":"H Okutani","year":"2018","unstructured":"Okutani, H., Yamanaka, H., Kobayashi, K., Okubo, M. & Noguchi, K. Recombinant interleukin-4 alleviates mechanical allodynia via injury-induced interleukin-4 receptor \u03b1 in spinal microglia in a rat model of neuropathic pain. Glia 66, 1775\u20131787 (2018).","journal-title":"Glia"},{"key":"777_CR77","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1126\/science.aaf8924","volume":"354","author":"RR Ji","year":"2016","unstructured":"Ji, R. R., Chamessian, A. & Zhang, Y. Q. Pain regulation by non-neuronal cells and inflammation. Science 354, 572\u2013577 (2016).","journal-title":"Science"},{"key":"777_CR78","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.bbi.2016.04.012","volume":"56","author":"NT Fiore","year":"2016","unstructured":"Fiore, N. T. & Austin, P. J. Are the emergence of affective disturbances in neuropathic pain states contingent on supraspinal neuroinflammation? Brain Behav. Immun. 56, 397\u2013411 (2016).","journal-title":"Brain Behav. Immun."},{"key":"777_CR79","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.neuroscience.2004.08.035","volume":"129","author":"G Moalem","year":"2004","unstructured":"Moalem, G., Xu, K. & Yu, L. T lymphocytes play a role in neuropathic pain following peripheral nerve injury in rats. Neuroscience 129, 767\u2013777 (2004).","journal-title":"Neuroscience"},{"key":"777_CR80","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jneuroim.2011.01.005","volume":"234","author":"T Leger","year":"2011","unstructured":"Leger, T., Grist, J., D\u2019Acquisto, F., Clark, A. K. & Malcangio, M. Glatiramer acetate attenuates neuropathic allodynia through modulation of adaptive immune cells. J. Neuroimmunol. 234, 19\u201326 (2011).","journal-title":"J. Neuroimmunol."},{"key":"777_CR81","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.bbi.2010.04.001","volume":"24","author":"D Labuz","year":"2010","unstructured":"Labuz, D., Schreiter, A., Schmidt, Y., Brack, A. & Machelska, H. T lymphocytes containing \u03b2-endorphin ameliorate mechanical hypersensitivity following nerve injury. Brain Behav. Immun. 24, 1045\u20131053 (2010).","journal-title":"Brain Behav. Immun."},{"key":"777_CR82","doi-asserted-by":"publisher","first-page":"596780","DOI":"10.3389\/fnins.2020.596780","volume":"14","author":"Z Xu","year":"2020","unstructured":"Xu, Z. et al. Pain relief dependent on IL-17-CD4+ T cell-\u03b2-endorphin axis in rat model of brachial plexus root avulsion after electroacupuncture therapy. Front. Neurosci. 14, 596780 (2020).","journal-title":"Front. Neurosci."},{"key":"777_CR83","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.cyto.2014.10.028","volume":"71","author":"JG Lees","year":"2015","unstructured":"Lees, J. G., Duffy, S. S., Perera, C. J. & Moalem-Taylor, G. Depletion of Foxp3+ regulatory T cells increases severity of mechanical allodynia and significantly alters systemic cytokine levels following peripheral nerve injury. Cytokine 71, 207\u2013214 (2015).","journal-title":"Cytokine"},{"key":"777_CR84","doi-asserted-by":"publisher","first-page":"813751","DOI":"10.3389\/fnins.2022.813751","volume":"16","author":"H Chen","year":"2022","unstructured":"Chen, H. et al. Exploring the correlation between the regulation of macrophages by regulatory t cells and peripheral neuropathic pain. Front. Neurosci. 16, 813751 (2022).","journal-title":"Front. Neurosci."},{"key":"777_CR85","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1038\/cr.2014.106","volume":"24","author":"XJ Liu","year":"2014","unstructured":"Liu, X. J. et al. Nociceptive neurons regulate innate and adaptive immunity and neuropathic pain through MyD88 adapter. Cell Res. 24, 1374\u20131377 (2014).","journal-title":"Cell Res."},{"key":"777_CR86","doi-asserted-by":"publisher","first-page":"893","DOI":"10.2147\/JPR.S301343","volume":"14","author":"R Hu","year":"2021","unstructured":"Hu, R., Zhang, J., Liu, X., Huang, D. & Cao, Y. Q. Low-dose interleukin-2 and regulatory T cell treatments attenuate punctate and dynamic mechanical allodynia in a mouse model of sciatic nerve injury. J. Pain Res. 14, 893\u2013906 (2021).","journal-title":"J. Pain Res."},{"key":"777_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0712-6","volume":"13","author":"J Heyn","year":"2016","unstructured":"Heyn, J. et al. miR-124a and miR-155 enhance differentiation of regulatory T cells in patients with neuropathic pain. J. Neuroinflammation 13, 248 (2016).","journal-title":"J. Neuroinflammation"},{"key":"777_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-014-0225-0","volume":"12","author":"B Luchting","year":"2015","unstructured":"Luchting, B. et al. Anti-inflammatory T-cell shift in neuropathic pain. J. Neuroinflammation 12, 12 (2015).","journal-title":"J. Neuroinflammation"},{"key":"777_CR89","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00403-013-1367-0","volume":"305","author":"Q Xing","year":"2013","unstructured":"Xing, Q., Hu, D., Shi, F. & Chen, F. Role of regulatory T cells in patients with acute herpes zoster and relationship to postherpetic neuralgia. Arch. Dermatol. Res. 305, 715\u2013722 (2013).","journal-title":"Arch. Dermatol. Res."},{"key":"777_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08123-6","volume":"7","author":"G Moalem-Taylor","year":"2017","unstructured":"Moalem-Taylor, G. et al. Immune dysregulation in patients with carpal tunnel syndrome. Sci. Rep. 7, 8218 (2017).","journal-title":"Sci. Rep."},{"key":"777_CR91","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41586-019-1467-x","volume":"572","author":"N Saligrama","year":"2019","unstructured":"Saligrama, N. et al. Opposing T cell responses in experimental autoimmune encephalomyelitis. Nature 572, 481\u2013487 (2019).","journal-title":"Nature"},{"key":"777_CR92","doi-asserted-by":"publisher","first-page":"11074","DOI":"10.1523\/JNEUROSCI.3708-15.2016","volume":"36","author":"K Krukowski","year":"2016","unstructured":"Krukowski, K. et al. CD8+ T cells and endogenous IL-10 are required for resolution of chemotherapy-induced neuropathic pain. J. Neurosci. 36, 11074\u201311083 (2016).","journal-title":"J. Neurosci."},{"key":"777_CR93","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1097\/j.pain.0000000000001512","volume":"160","author":"G Laumet","year":"2019","unstructured":"Laumet, G., Edralin, J. D., Dantzer, R., Heijnen, C. J. & Kavelaars, A. Cisplatin educates CD8+ T cells to prevent and resolve chemotherapy-induced peripheral neuropathy in mice. Pain 160, 1459\u20131468 (2019).","journal-title":"Pain"},{"key":"777_CR94","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1159\/000115041","volume":"14","author":"I Kaufmann","year":"2007","unstructured":"Kaufmann, I. et al. Lymphocyte subsets and the role of TH1\/TH2 balance in stressed chronic pain patients. Neuroimmunomodulation 14, 272\u2013280 (2007).","journal-title":"Neuroimmunomodulation"},{"key":"777_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16664-z","volume":"7","author":"DM Lopes","year":"2017","unstructured":"Lopes, D. M. et al. Sex differences in peripheral not central immune responses to pain-inducing injury. Sci. Rep. 7, 16460 (2017).","journal-title":"Sci. Rep."},{"key":"777_CR96","doi-asserted-by":"publisher","first-page":"9819","DOI":"10.1523\/JNEUROSCI.2053-17.2017","volume":"37","author":"SF Rosen","year":"2017","unstructured":"Rosen, S. F. et al. T-cell mediation of pregnancy analgesia affecting chronic pain in mice. J. Neurosci. 37, 9819\u20139827 (2017).","journal-title":"J. Neurosci."},{"key":"777_CR97","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/eji.200737485","volume":"38","author":"L Cao","year":"2008","unstructured":"Cao, L. & DeLeo, J. A. CNS-infiltrating CD4+ T lymphocytes contribute to murine spinal nerve transection-induced neuropathic pain. Eur. J. Immunol. 38, 448\u2013458 (2008).","journal-title":"Eur. J. Immunol."},{"key":"777_CR98","doi-asserted-by":"publisher","first-page":"14415","DOI":"10.1523\/JNEUROSCI.4569-09.2009","volume":"29","author":"M Costigan","year":"2009","unstructured":"Costigan, M. et al. T-cell infiltration and signaling in the adult dorsal spinal cord is a major contributor to neuropathic pain-like hypersensitivity. J. Neurosci. 29, 14415\u201314422 (2009).","journal-title":"J. Neurosci."},{"key":"777_CR99","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1097\/j.pain.0000000000001914","volume":"161","author":"Z Liang","year":"2020","unstructured":"Liang, Z. et al. A transcriptional toolbox for exploring peripheral neuroimmune interactions. Pain 161, 2089\u20132106 (2020).","journal-title":"Pain"},{"key":"777_CR100","doi-asserted-by":"publisher","first-page":"10807","DOI":"10.1074\/jbc.RA120.013696","volume":"295","author":"AV Chernov","year":"2020","unstructured":"Chernov, A. V. et al. A myelin basic protein fragment induces sexually dimorphic transcriptome signatures of neuropathic pain in mice. J. Biol. Chem. 295, 10807\u201310821 (2020).","journal-title":"J. Biol. Chem."},{"key":"777_CR101","doi-asserted-by":"publisher","first-page":"835800","DOI":"10.3389\/fncel.2022.835800","volume":"16","author":"HJ Lee","year":"2022","unstructured":"Lee, H. J. et al. Sex-specific B cell and anti-myelin autoantibody response after peripheral nerve injury. Front. Cell Neurosci. 16, 835800 (2022).","journal-title":"Front. Cell Neurosci."},{"key":"777_CR102","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/j.pain.0000000000002725","volume":"164","author":"TZ Guo","year":"2022","unstructured":"Guo, T. Z. et al. Pronociceptive autoantibodies in the spinal cord mediate nociceptive sensitization, loss of function, and spontaneous pain in the lumbar disc puncture model of chronic back pain. Pain 164, 421\u2013434 (2022).","journal-title":"Pain"},{"key":"777_CR103","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1016\/j.pain.2014.09.007","volume":"155","author":"WW Li","year":"2014","unstructured":"Li, W. W. et al. Autoimmunity contributes to nociceptive sensitization in a mouse model of complex regional pain syndrome. Pain 155, 2377\u20132389 (2014).","journal-title":"Pain"},{"key":"777_CR104","doi-asserted-by":"publisher","first-page":"13067","DOI":"10.1073\/pnas.1820168116","volume":"116","author":"Z Helyes","year":"2019","unstructured":"Helyes, Z. et al. Transfer of complex regional pain syndrome to mice via human autoantibodies is mediated by interleukin-1-induced mechanisms. Proc. Natl Acad. Sci. USA 116, 13067\u201313076 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"777_CR105","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1097\/j.pain.0000000000001046","volume":"158","author":"TZ Guo","year":"2017","unstructured":"Guo, T. Z. et al. Passive transfer autoimmunity in a mouse model of complex regional pain syndrome. Pain 158, 2410\u20132421 (2017).","journal-title":"Pain"},{"key":"777_CR106","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1097\/j.pain.0000000000001662","volume":"160","author":"U Cuhadar","year":"2019","unstructured":"Cuhadar, U. et al. Autoantibodies produce pain in complex regional pain syndrome by sensitizing nociceptors. Pain 160, 2855\u20132865 (2019).","journal-title":"Pain"},{"key":"777_CR107","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.pain.2006.09.008","volume":"129","author":"M de Mos","year":"2007","unstructured":"de Mos, M. et al. The incidence of complex regional pain syndrome: a population-based study. Pain 129, 12\u201320 (2007).","journal-title":"Pain"},{"key":"777_CR108","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1097\/01.ajp.0000210920.03289.93","volume":"22","author":"S Schneider","year":"2006","unstructured":"Schneider, S., Randoll, D. & Buchner, M. Why do women have back pain more than men? A representative prevalence study in the federal republic of Germany. Clin. J. Pain 22, 738\u2013747 (2006).","journal-title":"Clin. J. Pain"},{"key":"777_CR109","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/ana.21577","volume":"65","author":"MC Dalakas","year":"2009","unstructured":"Dalakas, M. C. et al. Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy. Ann. Neurol. 65, 286\u2013293 (2009).","journal-title":"Ann. Neurol."},{"key":"777_CR110","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","volume":"42","author":"EC Rosser","year":"2015","unstructured":"Rosser, E. C. & Mauri, C. Regulatory B cells: origin, phenotype, and function. Immunity 42, 607\u2013612 (2015).","journal-title":"Immunity"},{"key":"777_CR111","doi-asserted-by":"publisher","first-page":"806700","DOI":"10.3389\/fnmol.2021.806700","volume":"14","author":"D Hua","year":"2021","unstructured":"Hua, D. et al. Gut microbiome and plasma metabolome signatures in middle-aged mice with cognitive dysfunction induced by chronic neuropathic pain. Front. Mol. Neurosci. 14, 806700 (2021).","journal-title":"Front. Mol. Neurosci."},{"key":"777_CR112","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.adc8810","volume":"379","author":"K Mollgard","year":"2023","unstructured":"Mollgard, K. et al. A mesothelium divides the subarachnoid space into functional compartments. Science 379, 84\u201388 (2023).","journal-title":"Science"},{"key":"777_CR113","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1146\/annurev-immunol-102319-103410","volume":"38","author":"K Alves de Lima","year":"2020","unstructured":"Alves de Lima, K., Rustenhoven, J. & Kipnis, J. Meningeal immunity and its function in maintenance of the central nervous system in health and disease. Annu. Rev. Immunol. 38, 597\u2013620 (2020).","journal-title":"Annu. Rev. Immunol."},{"key":"777_CR114","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature14432","volume":"523","author":"A Louveau","year":"2015","unstructured":"Louveau, A. et al. Structural and functional features of central nervous system lymphatic vessels. Nature 523, 337\u2013341 (2015).","journal-title":"Nature"},{"key":"777_CR115","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf7844","author":"A Cugurra","year":"2021","unstructured":"Cugurra, A. et al. Skull and vertebral bone marrow are myeloid cell reservoirs for the meninges and CNS parenchyma. Science https:\/\/doi.org\/10.1126\/science.abf7844 (2021).","journal-title":"Science"},{"key":"777_CR116","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1115-7","volume":"15","author":"B Du","year":"2018","unstructured":"Du, B. et al. CD4+ \u03b1\u03b2 T cell infiltration into the leptomeninges of lumbar dorsal roots contributes to the transition from acute to chronic mechanical allodynia after adult rat tibial nerve injuries. J. Neuroinflammation 15, 81 (2018).","journal-title":"J. Neuroinflammation"},{"key":"777_CR117","doi-asserted-by":"publisher","DOI":"10.1172\/JCI153805","volume":"132","author":"AG Maganin","year":"2022","unstructured":"Maganin, A. G. et al. Meningeal dendritic cells drive neuropathic pain through elevation of the kynurenine metabolic pathway in mice. J. Clin. Invest. 132, e153805 (2022).","journal-title":"J. Clin. Invest."},{"key":"777_CR118","doi-asserted-by":"publisher","first-page":"10819","DOI":"10.1523\/JNEUROSCI.1642-11.2011","volume":"31","author":"S Echeverry","year":"2011","unstructured":"Echeverry, S., Shi, X. Q., Rivest, S. & Zhang, J. Peripheral nerve injury alters blood-spinal cord barrier functional and molecular integrity through a selective inflammatory pathway. J. Neurosci. 31, 10819\u201310828 (2011).","journal-title":"J. Neurosci."},{"key":"777_CR119","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202102153","volume":"11","author":"JF Alexander","year":"2022","unstructured":"Alexander, J. F. et al. Targeting the meningeal compartment to resolve chemobrain and neuropathy via nasal delivery of functionalized mitochondria. Adv. Healthc. Mater. 11, e2102153 (2022).","journal-title":"Adv. Healthc. Mater."},{"key":"777_CR120","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.7150\/thno.53474","volume":"11","author":"JF Alexander","year":"2021","unstructured":"Alexander, J. F. et al. Nasal administration of mitochondria reverses chemotherapy-induced cognitive deficits. Theranostics 11, 3109\u20133130 (2021).","journal-title":"Theranostics"},{"key":"777_CR121","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nn.4189","volume":"19","author":"Z Guan","year":"2016","unstructured":"Guan, Z. et al. Injured sensory neuron-derived CSF1 induces microglial proliferation and DAP12-dependent pain. Nat. Neurosci. 19, 94\u2013101 (2016).","journal-title":"Nat. Neurosci."},{"key":"777_CR122","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.immuni.2017.04.008","volume":"46","author":"Y Belkaid","year":"2017","unstructured":"Belkaid, Y. & Harrison, O. J. Homeostatic immunity and the microbiota. Immunity 46, 562\u2013576 (2017).","journal-title":"Immunity"},{"key":"777_CR123","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","volume":"19","author":"Y Fan","year":"2021","unstructured":"Fan, Y. & Pedersen, O. Gut microbiota in human metabolic health and disease. Nat. Rev. Microbiol. 19, 55\u201371 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"777_CR124","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.bja.2019.07.026","volume":"123","author":"R Guo","year":"2019","unstructured":"Guo, R., Chen, L. H., Xing, C. & Liu, T. Pain regulation by gut microbiota: molecular mechanisms and therapeutic potential. Br. J. Anaesth. 123, 637\u2013654 (2019).","journal-title":"Br. J. Anaesth."},{"key":"777_CR125","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1097\/j.pain.0000000000001640","volume":"160","author":"A Minerbi","year":"2019","unstructured":"Minerbi, A. et al. Altered microbiome composition in individuals with fibromyalgia. Pain 160, 2589\u20132602 (2019).","journal-title":"Pain"},{"key":"777_CR126","doi-asserted-by":"publisher","first-page":"105773","DOI":"10.1016\/j.nbd.2022.105773","volume":"170","author":"K Pane","year":"2022","unstructured":"Pane, K. et al. Role of gut microbiota in neuropathy and neuropathic pain states: a systematic preclinical review. Neurobiol. Dis. 170, 105773 (2022).","journal-title":"Neurobiol. Dis."},{"key":"777_CR127","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jpain.2021.08.006","volume":"23","author":"RJ Ellis","year":"2022","unstructured":"Ellis, R. J., Heaton, R. K., Gianella, S., Rahman, G. & Knight, R. Reduced gut microbiome diversity in people with HIV who have distal neuropathic pain. J. Pain 23, 318\u2013325 (2022).","journal-title":"J. Pain"},{"key":"777_CR128","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41579-020-00460-0","volume":"19","author":"LH Morais","year":"2021","unstructured":"Morais, L. H., Schreiber, H. L. T. & Mazmanian, S. K. The gut microbiota\u2013brain axis in behaviour and brain disorders. Nat. Rev. Microbiol. 19, 241\u2013255 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"777_CR129","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-021-00765-y","volume":"14","author":"P Chen","year":"2021","unstructured":"Chen, P. et al. Alterations in the gut microbiota and metabolite profiles in the context of neuropathic pain. Mol. Brain 14, 50 (2021).","journal-title":"Mol. Brain"},{"key":"777_CR130","doi-asserted-by":"publisher","first-page":"681","DOI":"10.2147\/JPR.S288289","volume":"14","author":"N Lian","year":"2021","unstructured":"Lian, N. et al. Drinking hydrogen-rich water alleviates chemotherapy-induced neuropathic pain through the regulation of gut microbiota. J. Pain Res. 14, 681\u2013691 (2021).","journal-title":"J. Pain Res."},{"key":"777_CR131","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02523-w","volume":"19","author":"P Ma","year":"2022","unstructured":"Ma, P. et al. Gut microbiota depletion by antibiotics ameliorates somatic neuropathic pain induced by nerve injury, chemotherapy, and diabetes in mice. J. Neuroinflammation 19, 169 (2022).","journal-title":"J. Neuroinflammation"},{"key":"777_CR132","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/nn.4606","volume":"20","author":"S Shen","year":"2017","unstructured":"Shen, S. et al. Gut microbiota is critical for the induction of chemotherapy-induced pain. Nat. Neurosci. 20, 1213\u20131216 (2017).","journal-title":"Nat. Neurosci."},{"key":"777_CR133","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1158\/1535-7163.MCT-15-0990","volume":"15","author":"HR Wardill","year":"2016","unstructured":"Wardill, H. R. et al. Irinotecan-induced gastrointestinal dysfunction and pain are mediated by common TLR4-dependent mechanisms. Mol. Cancer Ther. 15, 1376\u20131386 (2016).","journal-title":"Mol. Cancer Ther."},{"key":"777_CR134","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1172\/JCI64551","volume":"123","author":"F Alemi","year":"2013","unstructured":"Alemi, F. et al. The TGR5 receptor mediates bile acid-induced itch and analgesia. J. Clin. Invest. 123, 1513\u20131530 (2013).","journal-title":"J. Clin. Invest."},{"key":"777_CR135","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1097\/j.pain.0000000000002694","volume":"164","author":"A Minerbi","year":"2022","unstructured":"Minerbi, A. et al. Altered serum bile acid profile in fibromyalgia is associated with specific gut microbiome changes and symptom severity. Pain 164, e66\u2013e76 (2022).","journal-title":"Pain"},{"key":"777_CR136","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-56832-x","volume":"9","author":"C Ramakrishna","year":"2019","unstructured":"Ramakrishna, C. et al. Dominant role of the gut microbiota in chemotherapy induced neuropathic pain. Sci. Rep. 9, 20324 (2019).","journal-title":"Sci. Rep."},{"key":"777_CR137","doi-asserted-by":"publisher","DOI":"10.1177\/1744806921996520","volume":"17","author":"F Zhou","year":"2021","unstructured":"Zhou, F. et al. Short-chain fatty acids contribute to neuropathic pain via regulating microglia activation and polarization. Mol. Pain 17, 1744806921996520 (2021).","journal-title":"Mol. Pain"},{"key":"777_CR138","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-021-01007-y","volume":"9","author":"Y Jing","year":"2021","unstructured":"Jing, Y. et al. Effect of fecal microbiota transplantation on neurological restoration in a spinal cord injury mouse model: involvement of brain-gut axis. Microbiome 9, 59 (2021).","journal-title":"Microbiome"},{"key":"777_CR139","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1126\/science.abo5592","volume":"376","author":"G Sideris-Lampretsas","year":"2022","unstructured":"Sideris-Lampretsas, G. & Malcangio, M. Pain-resolving microglia. Science 376, 33\u201334 (2022).","journal-title":"Science"},{"key":"777_CR140","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nn.4030","volume":"18","author":"D Erny","year":"2015","unstructured":"Erny, D. et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci. 18, 965\u2013977 (2015).","journal-title":"Nat. Neurosci."},{"key":"777_CR141","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1213\/ANE.0000000000005155","volume":"132","author":"W Ding","year":"2021","unstructured":"Ding, W. et al. Gut microbiota influences neuropathic pain through modulating proinflammatory and anti-inflammatory T cells. Anesth. Analg. 132, 1146\u20131155 (2021).","journal-title":"Anesth. Analg."},{"key":"777_CR142","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nature12726","volume":"504","author":"N Arpaia","year":"2013","unstructured":"Arpaia, N. et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451\u2013455 (2013).","journal-title":"Nature"},{"key":"777_CR143","doi-asserted-by":"publisher","first-page":"701644","DOI":"10.3389\/fnut.2021.701644","volume":"8","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. Lactobacillus paracasei S16 alleviates lumbar disc herniation by modulating inflammation response and gut microbiota. Front. Nutr. 8, 701644 (2021).","journal-title":"Front. Nutr."},{"key":"777_CR144","doi-asserted-by":"publisher","first-page":"7428","DOI":"10.1523\/JNEUROSCI.1114-16.2016","volume":"36","author":"V Singh","year":"2016","unstructured":"Singh, V. et al. Microbiota dysbiosis controls the neuroinflammatory response after stroke. J. Neurosci. 36, 7428\u20137440 (2016).","journal-title":"J. Neurosci."},{"key":"777_CR145","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.1233521","volume":"339","author":"JG Markle","year":"2013","unstructured":"Markle, J. G. et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339, 1084\u20131088 (2013).","journal-title":"Science"},{"key":"777_CR146","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature13479","volume":"510","author":"CN Serhan","year":"2014","unstructured":"Serhan, C. N. Pro-resolving lipid mediators are leads for resolution physiology. Nature 510, 92\u2013101 (2014).","journal-title":"Nature"},{"key":"777_CR147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mam.2017.03.001","volume":"58","author":"CN Serhan","year":"2017","unstructured":"Serhan, C. N. Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology. Mol. Asp. Med. 58, 1\u201311 (2017).","journal-title":"Mol. Asp. Med."},{"key":"777_CR148","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00418-004-0695-8","volume":"122","author":"CN Serhan","year":"2004","unstructured":"Serhan, C. N. A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution. Histochem. Cell Biol. 122, 305\u2013321 (2004).","journal-title":"Histochem. Cell Biol."},{"key":"777_CR149","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1084\/jem.20020760","volume":"196","author":"CN Serhan","year":"2002","unstructured":"Serhan, C. N. et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196, 1025\u20131037 (2002).","journal-title":"J. Exp. Med."},{"key":"777_CR150","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.3389\/fimmu.2017.01400","volume":"8","author":"J Dalli","year":"2017","unstructured":"Dalli, J. & Serhan, C. N. Pro-resolving mediators in regulating and conferring macrophage function. Front. Immunol. 8, 1400 (2017).","journal-title":"Front. Immunol."},{"key":"777_CR151","doi-asserted-by":"publisher","first-page":"15178","DOI":"10.1073\/pnas.0405445101","volume":"101","author":"N Chiang","year":"2004","unstructured":"Chiang, N., Bermudez, E. A., Ridker, P. M., Hurwitz, S. & Serhan, C. N. Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial. Proc. Natl Acad. Sci. USA 101, 15178\u201315183 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"777_CR152","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nri.2015.4","volume":"16","author":"MC Basil","year":"2016","unstructured":"Basil, M. C. & Levy, B. D. Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nat. Rev. Immunol. 16, 51\u201367 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"777_CR153","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.bbalip.2014.08.006","volume":"1851","author":"CN Serhan","year":"2015","unstructured":"Serhan, C. N., Dalli, J., Colas, R. A., Winkler, J. W. & Chiang, N. Protectins and maresins: new pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome. Biochim. Biophys. Acta 1851, 397\u2013413 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"777_CR154","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.mam.2017.03.005","volume":"58","author":"N Chiang","year":"2017","unstructured":"Chiang, N. & Serhan, C. N. Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors. Mol. Asp. Med. 58, 114\u2013129 (2017).","journal-title":"Mol. Asp. Med."},{"key":"777_CR155","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1042\/EBC20200018","volume":"64","author":"N Chiang","year":"2020","unstructured":"Chiang, N. & Serhan, C. N. Specialized pro-resolving mediator network: an update on production and actions. Essays Biochem. 64, 443\u2013462 (2020).","journal-title":"Essays Biochem."},{"key":"777_CR156","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1096\/fj.201601222R","volume":"31","author":"CN Serhan","year":"2017","unstructured":"Serhan, C. N. Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms. FASEB J. 31, 1273\u20131288 (2017).","journal-title":"FASEB J."},{"key":"777_CR157","doi-asserted-by":"publisher","first-page":"8677","DOI":"10.4049\/jimmunol.181.12.8677","volume":"181","author":"K Kasuga","year":"2008","unstructured":"Kasuga, K. et al. Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution. J. Immunol. 181, 8677\u20138687 (2008).","journal-title":"J. Immunol."},{"key":"777_CR158","doi-asserted-by":"publisher","first-page":"5922","DOI":"10.1021\/cr100396c","volume":"111","author":"CN Serhan","year":"2011","unstructured":"Serhan, C. N. & Petasis, N. A. Resolvins and protectins in inflammation resolution. Chem. Rev. 111, 5922\u20135943 (2011).","journal-title":"Chem. Rev."},{"key":"777_CR159","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/bph.14336","volume":"176","author":"J Dalli","year":"2019","unstructured":"Dalli, J. & Serhan, C. N. Identification and structure elucidation of the pro-resolving mediators provides novel leads for resolution pharmacology. Br. J. Pharmacol. 176, 1024\u20131037 (2019).","journal-title":"Br. J. Pharmacol."},{"key":"777_CR160","doi-asserted-by":"publisher","first-page":"10370","DOI":"10.3390\/ijms221910370","volume":"22","author":"M Chavez-Castillo","year":"2021","unstructured":"Chavez-Castillo, M. et al. Specialized pro-resolving lipid mediators: the future of chronic pain therapy? Int. J. Mol. Sci. 22, 10370 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"777_CR161","doi-asserted-by":"publisher","first-page":"717993","DOI":"10.3389\/fphar.2021.717993","volume":"12","author":"A Leuti","year":"2021","unstructured":"Leuti, A., Fava, M., Pellegrini, N. & Maccarrone, M. Role of specialized pro-resolving mediators in neuropathic pain. Front. Pharmacol. 12, 717993 (2021).","journal-title":"Front. Pharmacol."},{"key":"777_CR162","doi-asserted-by":"publisher","first-page":"104549","DOI":"10.1016\/j.phrs.2019.104549","volume":"151","author":"V Fattori","year":"2020","unstructured":"Fattori, V., Zaninelli, T. H., Rasquel-Oliveira, F. S., Casagrande, R. & Verri, W. A. Jr Specialized pro-resolving lipid mediators: a new class of non-immunosuppressive and non-opioid analgesic drugs. Pharmacol. Res. 151, 104549 (2020).","journal-title":"Pharmacol. Res."},{"key":"777_CR163","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1515\/revneuro-2017-0074","volume":"29","author":"LY Zhang","year":"2018","unstructured":"Zhang, L. Y., Jia, M. R. & Sun, T. The roles of special proresolving mediators in pain relief. Rev. Neurosci. 29, 645\u2013660 (2018).","journal-title":"Rev. Neurosci."},{"key":"777_CR164","doi-asserted-by":"publisher","first-page":"781889","DOI":"10.3389\/fphar.2022.781889","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang, J., Li, Z., Fan, M. & Jin, W. Lipoxins in the nervous system: brighter prospects for neuroprotection. Front. Pharmacol. 13, 781889 (2022).","journal-title":"Front. Pharmacol."},{"key":"777_CR165","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.tins.2011.08.005","volume":"34","author":"RR Ji","year":"2011","unstructured":"Ji, R. R., Xu, Z. Z., Strichartz, G. & Serhan, C. N. Emerging roles of resolvins in the resolution of inflammation and pain. Trends Neurosci. 34, 599\u2013609 (2011).","journal-title":"Trends Neurosci."},{"key":"777_CR166","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3389\/fphar.2019.00745","volume":"10","author":"X Luo","year":"2019","unstructured":"Luo, X., Gu, Y., Tao, X., Serhan, C. N. & Ji, R. R. Resolvin D5 inhibits neuropathic and inflammatory pain in male but not female mice: distinct actions of D-series resolvins in chemotherapy-induced peripheral neuropathy. Front. Pharmacol. 10, 745 (2019).","journal-title":"Front. Pharmacol."},{"key":"777_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2022.12.013","author":"DF Baggio","year":"2022","unstructured":"Baggio, D. F. et al. Sex dimorphism in resolvin D5-induced analgesia in rat models of trigeminal pain. J. Pain https:\/\/doi.org\/10.1016\/j.jpain.2022.12.013 (2022).","journal-title":"J. Pain"},{"key":"777_CR168","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1097\/ALN.0000000000001010","volume":"124","author":"ZH Liu","year":"2016","unstructured":"Liu, Z. H. et al. Resolvin D1 inhibits mechanical hypersensitivity in sciatica by modulating the expression of nuclear factor-\u03baB, phospho-extracellular signal-regulated kinase, and pro- and antiinflammatory cytokines in the spinal cord and dorsal root ganglion. Anesthesiology 124, 934\u2013944 (2016).","journal-title":"Anesthesiology"},{"key":"777_CR169","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3389\/fphar.2018.00412","volume":"9","author":"L Zhang","year":"2018","unstructured":"Zhang, L. et al. Distinct analgesic actions of DHA and DHA-derived specialized pro-resolving mediators on post-operative pain after bone fracture in mice. Front. Pharmacol. 9, 412 (2018).","journal-title":"Front. Pharmacol."},{"key":"777_CR170","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jpain.2016.12.012","volume":"18","author":"JC Wang","year":"2017","unstructured":"Wang, J. C. & Strichartz, G. R. Prevention of chronic post-thoracotomy pain in rats by intrathecal resolvin D1 and D2: effectiveness of perioperative and delayed drug delivery. J. Pain 18, 535\u2013545 (2017).","journal-title":"J. Pain"},{"key":"777_CR171","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.pain.2010.11.021","volume":"152","author":"L Huang","year":"2011","unstructured":"Huang, L., Wang, C. F., Serhan, C. N. & Strichartz, G. Enduring prevention and transient reduction of postoperative pain by intrathecal resolvin D1. Pain 152, 557\u2013565 (2011).","journal-title":"Pain"},{"key":"777_CR172","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuropharm.2014.05.043","volume":"86","author":"CP Klein","year":"2014","unstructured":"Klein, C. P. et al. Effects of D-series resolvins on behavioral and neurochemical changes in a fibromyalgia-like model in mice. Neuropharmacology 86, 57\u201366 (2014).","journal-title":"Neuropharmacology"},{"key":"777_CR173","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/j.1476-5381.2010.00909.x","volume":"161","author":"S Bang","year":"2010","unstructured":"Bang, S. et al. Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception. Br. J. Pharmacol. 161, 707\u2013720 (2010).","journal-title":"Br. J. Pharmacol."},{"key":"777_CR174","doi-asserted-by":"publisher","first-page":"18433","DOI":"10.1523\/JNEUROSCI.4192-11.2011","volume":"31","author":"CK Park","year":"2011","unstructured":"Park, C. K. et al. Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1\/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1. J. Neurosci. 31, 18433\u201318438 (2011).","journal-title":"J. Neurosci."},{"key":"777_CR175","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1007\/s13311-020-00892-9","volume":"17","author":"X Tao","year":"2020","unstructured":"Tao, X., Lee, M. S., Donnelly, C. R. & Ji, R. R. Neuromodulation, specialized proresolving mediators, and resolution of pain. Neurotherapeutics 17, 886\u2013899 (2020).","journal-title":"Neurotherapeutics"},{"key":"777_CR176","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/joim.12871","volume":"286","author":"CN Serhan","year":"2019","unstructured":"Serhan, C. N., de la Rosa, X. & Jouvene, C. Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation. J. Intern. Med. 286, 240\u2013258 (2019).","journal-title":"J. Intern. Med."},{"key":"777_CR177","doi-asserted-by":"publisher","first-page":"687046","DOI":"10.3389\/fphys.2021.687046","volume":"12","author":"X Tao","year":"2021","unstructured":"Tao, X. et al. Spinal Cord stimulation attenuates mechanical allodynia and increases central resolvin D1 levels in rats with spared nerve injury. Front. Physiol. 12, 687046 (2021).","journal-title":"Front. Physiol."},{"key":"777_CR178","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21940-8","volume":"12","author":"S Bang","year":"2021","unstructured":"Bang, S. et al. Activation of GPR37 in macrophages confers protection against infection-induced sepsis and pain-like behaviour in mice. Nat. Commun. 12, 1704 (2021).","journal-title":"Nat. Commun."},{"key":"777_CR179","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/ana.23928","volume":"74","author":"ZZ Xu","year":"2013","unstructured":"Xu, Z. Z. et al. Neuroprotectin\/protectin D1 protects against neuropathic pain in mice after nerve trauma. Ann. Neurol. 74, 490\u2013495 (2013).","journal-title":"Ann. Neurol."},{"key":"777_CR180","doi-asserted-by":"publisher","first-page":"15072","DOI":"10.1523\/JNEUROSCI.2443-11.2011","volume":"31","author":"CK Park","year":"2011","unstructured":"Park, C. K. et al. Resolving TRPV1- and TNF-\u03b1-mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1. J. Neurosci. 31, 15072\u201315085 (2011).","journal-title":"J. Neurosci."},{"key":"777_CR181","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1039\/D0OB02136A","volume":"19","author":"JI Nesman","year":"2021","unstructured":"Nesman, J. I. et al. A new synthetic protectin D1 analog 3-oxa-PD1n-3 DPA reduces neuropathic pain and chronic itch in mice. Org. Biomol. Chem. 19, 2744\u20132752 (2021).","journal-title":"Org. Biomol. Chem."},{"key":"777_CR182","doi-asserted-by":"publisher","first-page":"100033","DOI":"10.1194\/jlr.TR120000954","volume":"62","author":"TL Pham","year":"2021","unstructured":"Pham, T. L. & Bazan, H. E. P. Docosanoid signaling modulates corneal nerve regeneration: effect on tear secretion, wound healing, and neuropathic pain. J. Lipid Res. 62, 100033 (2021).","journal-title":"J. Lipid Res."},{"key":"777_CR183","doi-asserted-by":"publisher","first-page":"18486","DOI":"10.1074\/jbc.M117.801472","volume":"292","author":"TL Pham","year":"2017","unstructured":"Pham, T. L. et al. Defining a mechanistic link between pigment epithelium-derived factor, docosahexaenoic acid, and corneal nerve regeneration. J. Biol. Chem. 292, 18486\u201318499 (2017).","journal-title":"J. Biol. Chem."},{"key":"777_CR184","doi-asserted-by":"publisher","first-page":"5294","DOI":"10.1172\/JCI129448","volume":"129","author":"N Chiang","year":"2019","unstructured":"Chiang, N., Libreros, S., Norris, P. C., de la Rosa, X. & Serhan, C. N. Maresin 1 activates LGR6 receptor promoting phagocyte immunoresolvent functions. J. Clin. Invest. 129, 5294\u20135311 (2019).","journal-title":"J. Clin. Invest."},{"key":"777_CR185","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1096\/fj.11-201442","volume":"26","author":"CN Serhan","year":"2012","unstructured":"Serhan, C. N. et al. Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain. FASEB J. 26, 1755\u20131765 (2012).","journal-title":"FASEB J."},{"key":"777_CR186","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1111\/bph.14647","volume":"176","author":"V Fattori","year":"2019","unstructured":"Fattori, V. et al. The specialised pro-resolving lipid mediator maresin 1 reduces inflammatory pain with a long-lasting analgesic effect. Br. J. Pharmacol. 176, 1728\u20131744 (2019).","journal-title":"Br. J. Pharmacol."},{"key":"777_CR187","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.2147\/JPR.S160779","volume":"11","author":"J Gao","year":"2018","unstructured":"Gao, J. et al. Pro-resolving mediator maresin 1 ameliorates pain hypersensitivity in a rat spinal nerve ligation model of neuropathic pain. J. Pain Res. 11, 1511\u20131519 (2018).","journal-title":"J. Pain Res."},{"key":"777_CR188","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3389\/fnins.2020.00831","volume":"14","author":"YH Wang","year":"2020","unstructured":"Wang, Y. H. et al. Maresin 1 attenuates radicular pain through the inhibition of NLRP3 inflammasome-induced pyroptosis via NF-\u03baB signaling. Front. Neurosci. 14, 831 (2020).","journal-title":"Front. Neurosci."},{"key":"777_CR189","doi-asserted-by":"publisher","first-page":"11731","DOI":"10.1523\/JNEUROSCI.1395-17.2017","volume":"37","author":"I Francos-Quijorna","year":"2017","unstructured":"Francos-Quijorna, I. et al. Maresin 1 promotes inflammatory resolution, neuroprotection, and functional neurological recovery after spinal cord injury. J. Neurosci. 37, 11731\u201311743 (2017).","journal-title":"J. Neurosci."},{"key":"777_CR190","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.4049\/jimmunol.1402166","volume":"194","author":"M Herov\u00e1","year":"2015","unstructured":"Herov\u00e1, M., Schmid, M., Gemperle, C. & Hersberger, M. ChemR23, the receptor for chemerin and resolvin E1, is expressed and functional on M1 but not on M2 macrophages. J. Immunol. 194, 2330\u20132337 (2015).","journal-title":"J. Immunol."},{"key":"777_CR191","doi-asserted-by":"publisher","first-page":"673549","DOI":"10.3389\/fncel.2021.673549","volume":"15","author":"M Tiberi","year":"2021","unstructured":"Tiberi, M. & Chiurchiu, V. Specialized pro-resolving lipid mediators and glial cells: emerging candidates for brain homeostasis and repair. Front. Cell. Neurosci. 15, 673549 (2021).","journal-title":"Front. Cell. Neurosci."},{"key":"777_CR192","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.4049\/jimmunol.178.6.3912","volume":"178","author":"M Arita","year":"2007","unstructured":"Arita, M. et al. Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J. Immunol. 178, 3912\u20133917 (2007).","journal-title":"J. Immunol."},{"key":"777_CR193","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11481-012-9394-8","volume":"8","author":"ZZ Xu","year":"2013","unstructured":"Xu, Z. Z., Berta, T. & Ji, R. R. Resolvin E1 inhibits neuropathic pain and spinal cord microglial activation following peripheral nerve injury. J. Neuroimmune Pharmacol. 8, 37\u201341 (2013).","journal-title":"J. Neuroimmune Pharmacol."},{"key":"777_CR194","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nm.2123","volume":"16","author":"ZZ Xu","year":"2010","unstructured":"Xu, Z. Z. et al. Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nat. Med. 16, 592\u2013597 (2010).","journal-title":"Nat. Med."},{"key":"777_CR195","doi-asserted-by":"publisher","first-page":"5259321","DOI":"10.1155\/2016\/5259321","volume":"2016","author":"YY Jo","year":"2016","unstructured":"Jo, Y. Y., Lee, J. Y. & Park, C. K. Resolvin E1 inhibits substance P-induced potentiation of TRPV1 in primary sensory neurons. Mediators Inflamm. 2016, 5259321 (2016).","journal-title":"Mediators Inflamm."},{"key":"777_CR196","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1007\/s12272-010-1004-9","volume":"33","author":"S Bang","year":"2010","unstructured":"Bang, S., Yoo, S., Oh, U. & Hwang, S. W. Endogenous lipid-derived ligands for sensory TRP ion channels and their pain modulation. Arch. Pharm. Res. 33, 1509\u20131520 (2010).","journal-title":"Arch. Pharm. Res."},{"key":"777_CR197","doi-asserted-by":"publisher","first-page":"584206","DOI":"10.3389\/fcell.2020.584206","volume":"8","author":"J Roh","year":"2020","unstructured":"Roh, J., Go, E. J., Park, J. W., Kim, Y. H. & Park, C. K. Resolvins: potent pain inhibiting lipid mediators via transient receptor potential regulation. Front. Cell. Dev. Biol. 8, 584206 (2020).","journal-title":"Front. Cell. Dev. Biol."},{"key":"777_CR198","doi-asserted-by":"crossref","unstructured":"Nolan, K. & Godson, C. in Encyclopedia of Signaling Molecules (ed. Choi, S.) 1854\u20131862 (Springer, 2018).","DOI":"10.1007\/978-3-319-67199-4_590"},{"key":"777_CR199","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01918-x","volume":"17","author":"GJ Liu","year":"2020","unstructured":"Liu, G. J. et al. Functions of resolvin D1-ALX\/FPR2 receptor interaction in the hemoglobin-induced microglial inflammatory response and neuronal injury. J. Neuroinflammation 17, 239 (2020).","journal-title":"J. Neuroinflammation"},{"key":"777_CR200","doi-asserted-by":"publisher","first-page":"18232","DOI":"10.1073\/pnas.1308253110","volume":"110","author":"SN Cooray","year":"2013","unstructured":"Cooray, S. N. et al. Ligand-specific conformational change of the G-protein\u2013coupled receptor ALX\/FPR2 determines proresolving functional responses. Proc. Natl Acad. Sci. USA 110, 18232\u201318237 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"777_CR201","doi-asserted-by":"publisher","first-page":"113167","DOI":"10.1016\/j.ejmech.2021.113167","volume":"213","author":"M Maciuszek","year":"2021","unstructured":"Maciuszek, M., Cacace, A., Brennan, E., Godson, C. & Chapman, T. M. Recent advances in the design and development of formyl peptide receptor 2 (FPR2\/ALX) agonists as pro-resolving agents with diverse therapeutic potential. Eur. J. Med. Chem. 213, 113167 (2021).","journal-title":"Eur. J. Med. Chem."},{"key":"777_CR202","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejpain.2011.05.005","volume":"16","author":"T Sun","year":"2012","unstructured":"Sun, T. et al. Lipoxin A4 induced antinociception and decreased expression of NF-\u03baB and pro-inflammatory cytokines after chronic dorsal root ganglia compression in rats. Eur. J. Pain 16, 18\u201327 (2012).","journal-title":"Eur. J. Pain"},{"key":"777_CR203","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0540-8","volume":"13","author":"AC Martini","year":"2016","unstructured":"Martini, A. C. et al. Lipoxin A4 inhibits microglial activation and reduces neuroinflammation and neuropathic pain after spinal cord hemisection. J. Neuroinflammation 13, 75 (2016).","journal-title":"J. Neuroinflammation"},{"key":"777_CR204","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1084\/jem.20061826","volume":"204","author":"CI Svensson","year":"2007","unstructured":"Svensson, C. I., Zattoni, M. & Serhan, C. N. Lipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processing. J. Exp. Med. 204, 245\u2013252 (2007).","journal-title":"J. Exp. Med."},{"key":"777_CR205","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.neuroscience.2015.04.060","volume":"300","author":"GS Miao","year":"2015","unstructured":"Miao, G. S. et al. Lipoxin A4 attenuates radicular pain possibly by inhibiting spinal ERK, JNK and NF-\u03baB\/p65 and cytokine signals, but not p38, in a rat model of non-compressive lumbar disc herniation. Neuroscience 300, 10\u201318 (2015).","journal-title":"Neuroscience"},{"key":"777_CR206","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neuroscience.2014.04.052","volume":"273","author":"ZF Wang","year":"2014","unstructured":"Wang, Z. F. et al. Aspirin-triggered lipoxin A4 attenuates mechanical allodynia in association with inhibiting spinal JAK2\/STAT3 signaling in neuropathic pain in rats. Neuroscience 273, 65\u201378 (2014).","journal-title":"Neuroscience"},{"key":"777_CR207","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.neuroscience.2013.09.028","volume":"254","author":"Q Li","year":"2013","unstructured":"Li, Q. et al. Involvement of the spinal NALP1 inflammasome in neuropathic pain and aspirin-triggered-15-epi-lipoxin A4 induced analgesia. Neuroscience 254, 230\u2013240 (2013).","journal-title":"Neuroscience"},{"key":"777_CR208","first-page":"12826","volume":"8","author":"ZQ Liu","year":"2015","unstructured":"Liu, Z. Q., Zhang, H. B., Wang, J., Xia, L. J. & Zhang, W. Lipoxin A4 ameliorates ischemia\/reperfusion induced spinal cord injury in rabbit model. Int. J. Clin. Exp. Med. 8, 12826\u201312833 (2015).","journal-title":"Int. J. Clin. Exp. Med."},{"key":"777_CR209","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","volume":"14","author":"NB Finnerup","year":"2015","unstructured":"Finnerup, N. B. et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 14, 162\u2013173 (2015).","journal-title":"Lancet Neurol."},{"key":"777_CR210","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1097\/j.pain.0000000000001164","volume":"159","author":"A Veluchamy","year":"2018","unstructured":"Veluchamy, A., H\u00e9bert, H. L., Meng, W., Palmer, C. N. A. & Smith, B. H. Systematic review and meta-analysis of genetic risk factors for neuropathic pain. Pain 159, 825\u2013848 (2018).","journal-title":"Pain"},{"key":"777_CR211","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.bbi.2018.09.018","volume":"75","author":"DS Albrecht","year":"2019","unstructured":"Albrecht, D. S. et al. Brain glial activation in fibromyalgia \u2014 a multi-site positron emission tomography investigation. Brain Behav. Immun. 75, 72\u201383 (2019).","journal-title":"Brain Behav. Immun."},{"key":"777_CR212","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/brain\/awu377","volume":"138","author":"ML Loggia","year":"2015","unstructured":"Loggia, M. L. et al. Evidence for brain glial activation in chronic pain patients. Brain 138, 604\u2013615 (2015).","journal-title":"Brain"},{"key":"777_CR213","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/ner.12866","volume":"22","author":"N Gravius","year":"2019","unstructured":"Gravius, N. et al. Selective L4 dorsal root ganglion stimulation evokes pain relief and changes of inflammatory markers: part I, profiling of saliva and serum molecular patterns. Neuromodulation 22, 44\u201352 (2019).","journal-title":"Neuromodulation"},{"key":"777_CR214","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-1952-x","volume":"17","author":"TM Kinfe","year":"2019","unstructured":"Kinfe, T. M. et al. Unilateral L4-dorsal root ganglion stimulation evokes pain relief in chronic neuropathic postsurgical knee pain and changes of inflammatory markers: part II, whole transcriptome profiling. J. Transl. Med. 17, 205 (2019).","journal-title":"J. Transl. Med."},{"key":"777_CR215","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/ner.12704","volume":"21","author":"N Kriek","year":"2018","unstructured":"Kriek, N. et al. Spinal cord stimulation in patients with complex regional pain syndrome: a possible target for immunomodulation. Neuromodulation 21, 77\u201386 (2018).","journal-title":"Neuromodulation"},{"key":"777_CR216","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbi.2018.02.010","volume":"70","author":"B Das","year":"2018","unstructured":"Das, B., Conroy, M., Moore, D., Lysaght, J. & McCrory, C. Human dorsal root ganglion pulsed radiofrequency treatment modulates cerebrospinal fluid lymphocytes and neuroinflammatory markers in chronic radicular pain. Brain Behav. Immun. 70, 157\u2013165 (2018).","journal-title":"Brain Behav. Immun."},{"key":"777_CR217","doi-asserted-by":"publisher","first-page":"577219","DOI":"10.1016\/j.jneuroim.2020.577219","volume":"343","author":"D Moore","year":"2020","unstructured":"Moore, D. et al. Characterisation of the effects of pulsed radio frequency treatment of the dorsal root ganglion on cerebrospinal fluid cellular and peptide constituents in patients with chronic radicular pain: a randomised, triple-blinded, controlled trial. J. Neuroimmunol. 343, 577219 (2020).","journal-title":"J. Neuroimmunol."},{"key":"777_CR218","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12877-019-1237-5","volume":"19","author":"P Chatterjee","year":"2019","unstructured":"Chatterjee, P. et al. Effect of deep tissue laser therapy treatment on peripheral neuropathic pain in older adults with type 2 diabetes: a pilot randomized clinical trial. BMC Geriatr. 19, 218 (2019).","journal-title":"BMC Geriatr."},{"key":"777_CR219","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.7150\/ijms.46038","volume":"17","author":"EM Choi","year":"2020","unstructured":"Choi, E. M. et al. Efficacy of intermittent epidural dexamethasone bolus for zoster-associated pain beyond the acute phase. Int. J. Med. Sci. 17, 1811\u20131818 (2020).","journal-title":"Int. J. Med. Sci."},{"key":"777_CR220","first-page":"287","volume":"24","author":"A Kikuchi","year":"1999","unstructured":"Kikuchi, A. et al. Comparative therapeutic evaluation of intrathecal versus epidural methylprednisolone for long-term analgesia in patients with intractable postherpetic neuralgia. Reg. Anesth. Pain Med. 24, 287\u2013293 (1999).","journal-title":"Reg. Anesth. Pain Med."},{"key":"777_CR221","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S1246-7820(03)00035-1","volume":"10","author":"J Bayry","year":"2003","unstructured":"Bayry, J. et al. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases. Transfus. Clin. Biol. 10, 165\u2013169 (2003).","journal-title":"Transfus. Clin. Biol."},{"key":"777_CR222","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/ene.14056","volume":"27","author":"HP Hartung","year":"2020","unstructured":"Hartung, H. P. et al. Patient-reported outcomes with subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy: the PATH study. Eur. J. Neurol. 27, 196\u2013203 (2020).","journal-title":"Eur. J. Neurol."},{"key":"777_CR223","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-015-0301-9","volume":"15","author":"YH Huang","year":"2015","unstructured":"Huang, Y. H. et al. Intravenous immunoglobulin for postpolio syndrome: a systematic review and meta-analysis. BMC Neurol. 15, 39 (2015).","journal-title":"BMC Neurol."},{"key":"777_CR224","first-page":"31","volume":"30","author":"M Sumitani","year":"2016","unstructured":"Sumitani, M. et al. Minocycline does not decrease intensity of neuropathic pain, but does improve its affective dimension. J. Pain Palliat. Care Pharmacother. 30, 31\u201335 (2016).","journal-title":"J. Pain Palliat. Care Pharmacother."},{"key":"777_CR225","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.tox.2016.07.016","volume":"365","author":"T Nishida","year":"2016","unstructured":"Nishida, T. et al. Involvement of high mobility group Box 1 in the development and maintenance of chemotherapy-induced peripheral neuropathy in rats. Toxicology 365, 48\u201358 (2016).","journal-title":"Toxicology"},{"key":"777_CR226","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00280-020-04135-8","volume":"86","author":"M Kotaka","year":"2020","unstructured":"Kotaka, M. et al. A placebo-controlled, double-blind, randomized study of recombinant thrombomodulin (ART-123) to prevent oxaliplatin-induced peripheral neuropathy. Cancer Chemother. Pharmacol. 86, 607\u2013618 (2020).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"777_CR227","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1212\/WNL.0000000000000317","volume":"82","author":"M Araki","year":"2014","unstructured":"Araki, M. et al. Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot study. Neurology 82, 1302\u20131306 (2014).","journal-title":"Neurology"},{"key":"777_CR228","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/BRS.0b013e318238af83","volume":"37","author":"S Ohtori","year":"2012","unstructured":"Ohtori, S. et al. Epidural administration of spinal nerves with the tumor necrosis factor-\u03b1 inhibitor, etanercept, compared with dexamethasone for treatment of sciatica in patients with lumbar spinal stenosis: a prospective randomized study. Spine 37, 439\u2013444 (2012).","journal-title":"Spine"},{"key":"777_CR229","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1097\/ALN.0b013e3181a05aa0","volume":"110","author":"SP Cohen","year":"2009","unstructured":"Cohen, S. P. et al. Randomized, double-blind, placebo-controlled, dose-response, and preclinical safety study of transforaminal epidural etanercept for the treatment of sciatica. Anesthesiology 110, 1116\u20131126 (2009).","journal-title":"Anesthesiology"},{"key":"777_CR230","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s00586-012-2183-5","volume":"21","author":"S Ohtori","year":"2012","unstructured":"Ohtori, S. et al. Efficacy of epidural administration of anti-interleukin-6 receptor antibody onto spinal nerve for treatment of sciatica. Eur. Spine J. 21, 2079\u20132084 (2012).","journal-title":"Eur. Spine J."},{"key":"777_CR231","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1002\/art.27499","volume":"62","author":"S Genevay","year":"2010","unstructured":"Genevay, S. et al. Adalimumab in severe and acute sciatica: a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 62, 2339\u20132346 (2010).","journal-title":"Arthritis Rheum."},{"key":"777_CR232","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1136\/annrheumdis-2011-200373","volume":"71","author":"S Genevay","year":"2012","unstructured":"Genevay, S. et al. Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trial. Ann. Rheum. Dis. 71, 560\u2013562 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"777_CR233","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1097\/01.BRS.0000058944.38900.CE","volume":"28","author":"J Karppinen","year":"2003","unstructured":"Karppinen, J. et al. Tumor necrosis factor-\u03b1 monoclonal antibody, infliximab, used to manage severe sciatica. Spine 28, 750\u2013754 (2003).","journal-title":"Spine"},{"key":"777_CR234","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1007\/s00586-013-2739-z","volume":"22","author":"NH Williams","year":"2013","unstructured":"Williams, N. H. et al. A systematic review and meta-analysis of biological treatments targeting tumour necrosis factor \u03b1 for sciatica. Eur. Spine J. 22, 1921\u20131935 (2013).","journal-title":"Eur. Spine J."},{"key":"777_CR235","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.bbi.2020.08.005","volume":"90","author":"LR Watkins","year":"2020","unstructured":"Watkins, L. R. et al. Targeted interleukin-10 plasmid DNA therapy in the treatment of osteoarthritis: toxicology and pain efficacy assessments. Brain Behav. Immun. 90, 155\u2013166 (2020).","journal-title":"Brain Behav. Immun."},{"key":"777_CR236","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1136\/annrheumdis-2018-214229","volume":"78","author":"M Rosenzwajg","year":"2019","unstructured":"Rosenzwajg, M. et al. Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial. Ann. Rheum. Dis. 78, 209\u2013217 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"777_CR237","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/jnr.24073","volume":"96","author":"SS Duffy","year":"2018","unstructured":"Duffy, S. S., Keating, B. A., Perera, C. J. & Moalem-Taylor, G. The role of regulatory T cells in nervous system pathologies. J. Neurosci. Res. 96, 951\u2013968 (2018).","journal-title":"J. Neurosci. Res."},{"key":"777_CR238","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jgg.2022.05.005","volume":"49","author":"G Qu","year":"2022","unstructured":"Qu, G. et al. Current status and perspectives of regulatory T cell-based therapy. J. Genet. Genom. 49, 599\u2013611 (2022).","journal-title":"J. Genet. Genom."},{"key":"777_CR239","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3727\/096368915X690279","volume":"25","author":"ER Chernykh","year":"2016","unstructured":"Chernykh, E. R. et al. Safety and therapeutic potential of M2 macrophages in stroke treatment. Cell Transpl. 25, 1461\u20131471 (2016).","journal-title":"Cell Transpl."},{"key":"777_CR240","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/sji.12162","volume":"79","author":"S Mia","year":"2014","unstructured":"Mia, S., Warnecke, A., Zhang, X. M., Malmstr\u00f6m, V. & Harris, R. A. An optimized protocol for human M2 macrophages using M-CSF and IL-4\/IL-10\/TGF-\u03b2 yields a dominant immunosuppressive phenotype. Scand. J. Immunol. 79, 305\u2013314 (2014).","journal-title":"Scand. J. Immunol."},{"key":"777_CR241","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1182\/blood-2004-07-2974","volume":"105","author":"JS Miller","year":"2005","unstructured":"Miller, J. S. et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood 105, 3051\u20133057 (2005).","journal-title":"Blood"},{"key":"777_CR242","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01170-x","volume":"21","author":"B Lin","year":"2020","unstructured":"Lin, B. et al. Gut microbiota regulates neuropathic pain: potential mechanisms and therapeutic strategy. J. Headache Pain 21, 103 (2020).","journal-title":"J. Headache Pain"},{"key":"777_CR243","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1007\/s10620-011-1728-5","volume":"56","author":"M Pimentel","year":"2011","unstructured":"Pimentel, M. et al. Effects of rifaximin treatment and retreatment in nonconstipated IBS subjects. Dig. Dis. Sci. 56, 2067\u20132072 (2011).","journal-title":"Dig. Dis. Sci."},{"key":"777_CR244","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41579-021-00667-9","volume":"20","author":"MT Sorbara","year":"2022","unstructured":"Sorbara, M. T. & Pamer, E. G. Microbiome-based therapeutics. Nat. Rev. Microbiol. 20, 365\u2013380 (2022).","journal-title":"Nat. Rev. Microbiol."},{"key":"777_CR245","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/apt.14539","volume":"47","author":"APS Hungin","year":"2018","unstructured":"Hungin, A. P. S. et al. Systematic review: probiotics in the management of lower gastrointestinal symptoms \u2014 an updated evidence-based international consensus. Aliment. Pharmacol. Ther. 47, 1054\u20131070 (2018).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"777_CR246","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6882-10-1","volume":"10","author":"DR Mandel","year":"2010","unstructured":"Mandel, D. R., Eichas, K. & Holmes, J. Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial. BMC Complement. Altern. Med. 10, 1 (2010).","journal-title":"BMC Complement. Altern. Med."},{"key":"777_CR247","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.nut.2013.09.007","volume":"30","author":"E Vaghef-Mehrabany","year":"2014","unstructured":"Vaghef-Mehrabany, E. et al. Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis. Nutrition 30, 430\u2013435 (2014).","journal-title":"Nutrition"},{"key":"777_CR248","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1172\/JCI92390","volume":"128","author":"SY Zhou","year":"2018","unstructured":"Zhou, S. Y. et al. FODMAP diet modulates visceral nociception by lipopolysaccharide-mediated intestinal inflammation and barrier dysfunction. J. Clin. Invest. 128, 267\u2013280 (2018).","journal-title":"J. Clin. Invest."},{"key":"777_CR249","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.146529","author":"P Singh","year":"2021","unstructured":"Singh, P. et al. High FODMAP diet causes barrier loss via lipopolysaccharide-mediated mast cell activation. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.146529 (2021).","journal-title":"JCI Insight"},{"key":"777_CR250","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0625-4","volume":"13","author":"DJ Allison","year":"2016","unstructured":"Allison, D. J., Thomas, A., Beaudry, K. & Ditor, D. S. Targeting inflammation as a treatment modality for neuropathic pain in spinal cord injury: a randomized clinical trial. J. Neuroinflammation 13, 152 (2016).","journal-title":"J. Neuroinflammation"},{"key":"777_CR251","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s40122-022-00391-z","volume":"11","author":"I Casini","year":"2022","unstructured":"Casini, I. et al. Food-specific IgG4 antibody-guided exclusion diet improves conditions of patients with chronic pain. Pain Ther. 11, 873\u2013906 (2022).","journal-title":"Pain Ther."},{"key":"777_CR252","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fcimb.2020.00098","volume":"10","author":"KEW Vendrik","year":"2020","unstructured":"Vendrik, K. E. W. et al. Fecal microbiota transplantation in neurological disorders. Front. Cell Infect. Microbiol. 10, 98 (2020).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"777_CR253","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","volume":"381","author":"Z DeFilipp","year":"2019","unstructured":"DeFilipp, Z. et al. Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant. N. Engl. J. Med. 381, 2043\u20132050 (2019).","journal-title":"N. Engl. J. Med."},{"key":"777_CR254","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4236\/ojgas.2017.74015","volume":"7","author":"T Thurm","year":"2017","unstructured":"Thurm, T., Ablin, J., Buskila, D. & Maharshak, N. Fecal microbiota transplantation for fibromyalgia: a case report and review of the literature. Open J. Gastroenterol. 7, 131\u2013139 (2017).","journal-title":"Open J. Gastroenterol."},{"key":"777_CR255","doi-asserted-by":"publisher","first-page":"838782","DOI":"10.3389\/fphar.2022.838782","volume":"13","author":"NH Schebb","year":"2022","unstructured":"Schebb, N. H. et al. Formation, signaling and occurrence of specialized pro-resolving lipid mediators-what is the evidence so far? Front. Pharmacol. 13, 838782 (2022).","journal-title":"Front. Pharmacol."},{"key":"777_CR256","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2147\/DMSO.S187268","volume":"12","author":"AM Duran","year":"2019","unstructured":"Duran, A. M. et al. Effects of omega-3 polyunsaturated fatty-acid supplementation on neuropathic pain symptoms and sphingosine levels in Mexican-Americans with type 2 diabetes. Diabetes Metab. Syndr. Obes. 12, 109\u2013120 (2019).","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"777_CR257","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3390\/nu14040761","volume":"14","author":"AM Duran","year":"2022","unstructured":"Duran, A. M., Beeson, W. L., Firek, A., Cordero-MacIntyre, Z. & De Leon, M. Dietary omega-3 polyunsaturated fatty-acid supplementation upregulates protective cellular pathways in patients with type 2 diabetes exhibiting improvement in painful diabetic neuropathy. Nutrients 14, 761 (2022).","journal-title":"Nutrients"},{"key":"777_CR258","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/AJP.0b013e3181bb8533","volume":"26","author":"GD Ko","year":"2010","unstructured":"Ko, G. D., Nowacki, N. B., Arseneau, L., Eitel, M. & Hum, A. Omega-3 fatty acids for neuropathic pain: case series. Clin. J. Pain 26, 168\u2013172 (2010).","journal-title":"Clin. J. Pain"},{"key":"777_CR259","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.plefa.2016.03.004","volume":"107","author":"AE Barden","year":"2016","unstructured":"Barden, A. E. et al. Specialised pro-resolving mediators of inflammation in inflammatory arthritis. Prostaglandins Leukot. Essent. Fat. Acids 107, 24\u201329 (2016).","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"777_CR260","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/01.j.pain.0000460348.84965.47","volume":"156","author":"CE Ramsden","year":"2015","unstructured":"Ramsden, C. E. et al. Targeted alterations in dietary n-3 and n-6 fatty acids improve life functioning and reduce psychological distress among patients with chronic headache: a secondary analysis of a randomized trial. Pain 156, 587\u2013596 (2015).","journal-title":"Pain"},{"key":"777_CR261","first-page":"21","volume":"11","author":"M Tajmirriahi","year":"2012","unstructured":"Tajmirriahi, M. et al. The effects of sodium valproate with fish oil supplementation or alone in migraine prevention: a randomized single-blind clinical trial. Iran. J. Neurol. 11, 21\u201324 (2012).","journal-title":"Iran. J. Neurol."},{"key":"777_CR262","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1523\/JNEUROSCI.05-11-03025.1985","volume":"5","author":"JD Levine","year":"1985","unstructured":"Levine, J. D., Gooding, J., Donatoni, P., Borden, L. & Goetzl, E. J. The role of the polymorphonuclear leukocyte in hyperalgesia. J. Neurosci. 5, 3025\u20133029 (1985).","journal-title":"J. Neurosci."},{"key":"777_CR263","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S0306-4522(00)00396-1","volume":"101","author":"NM Perkins","year":"2000","unstructured":"Perkins, N. M. & Tracey, D. J. Hyperalgesia due to nerve injury: role of neutrophils. Neuroscience 101, 745\u2013757 (2000).","journal-title":"Neuroscience"},{"key":"777_CR264","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0304-3959(03)00261-6","volume":"105","author":"Y Zuo","year":"2003","unstructured":"Zuo, Y., Perkins, N. M., Tracey, D. J. & Geczy, C. L. Inflammation and hyperalgesia induced by nerve injury in the rat: a key role of mast cells. Pain 105, 467\u2013479 (2003).","journal-title":"Pain"},{"key":"777_CR265","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/j.1532-2149.2012.00240.x","volume":"17","author":"EU Carreira","year":"2013","unstructured":"Carreira, E. U. et al. Neutrophils recruited by CXCR1\/2 signalling mediate post-incisional pain. Eur. J. Pain 17, 654\u2013663 (2013).","journal-title":"Eur. J. Pain"},{"key":"777_CR266","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1097\/j.pain.0000000000001596","volume":"160","author":"Y Harada","year":"2019","unstructured":"Harada, Y. et al. Cathepsin E in neutrophils contributes to the generation of neuropathic pain in experimental autoimmune encephalomyelitis. Pain 160, 2050\u20132062 (2019).","journal-title":"Pain"},{"key":"777_CR267","doi-asserted-by":"publisher","DOI":"10.1101\/2022.06.29.498149","author":"SB Caxaria","year":"2022","unstructured":"Caxaria, S. B. et al. Neutrophils infiltrate sensory ganglia and mediate chronic 1 widespread pain in fibromyalgia. Preprint at\u00a0bioRxiv https:\/\/doi.org\/10.1101\/2022.06.29.498149 (2022).","journal-title":"bioRxiv"},{"key":"777_CR268","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jneuroim.2006.12.009","volume":"184","author":"N Morin","year":"2007","unstructured":"Morin, N. et al. Neutrophils invade lumbar dorsal root ganglia after chronic constriction injury of the sciatic nerve. J. Neuroimmunol. 184, 164\u2013171 (2007).","journal-title":"J. Neuroimmunol."},{"key":"777_CR269","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.brainres.2011.06.022","volume":"1405","author":"CF Kim","year":"2011","unstructured":"Kim, C. F. & Moalem-Taylor, G. Detailed characterization of neuro-immune responses following neuropathic injury in mice. Brain Res. 1405, 95\u2013108 (2011).","journal-title":"Brain Res."},{"key":"777_CR270","doi-asserted-by":"publisher","first-page":"10258","DOI":"10.1523\/JNEUROSCI.2085-17.2017","volume":"37","author":"JA Lindborg","year":"2017","unstructured":"Lindborg, J. A., Mack, M. & Zigmond, R. E. Neutrophils are critical for myelin removal in a peripheral nerve injury model of Wallerian degeneration. J. Neurosci. 37, 10258\u201310277 (2017).","journal-title":"J. Neurosci."},{"key":"777_CR271","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0304-3959(00)00331-6","volume":"88","author":"JG Cui","year":"2000","unstructured":"Cui, J. G., Holmin, S., Mathiesen, T., Meyerson, B. A. & Linderoth, B. Possible role of inflammatory mediators in tactile hypersensitivity in rat models of mononeuropathy. Pain 88, 239\u2013248 (2000).","journal-title":"Pain"},{"key":"777_CR272","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ni1582","volume":"9","author":"E Vivier","year":"2008","unstructured":"Vivier, E., Tomasello, E., Baratin, M., Walzer, T. & Ugolini, S. Functions of natural killer cells. Nat. Immunol. 9, 503\u2013510 (2008).","journal-title":"Nat. Immunol."},{"key":"777_CR273","doi-asserted-by":"publisher","DOI":"10.1136\/bmjos-2021-100235","volume":"6","author":"N Shinotsuka","year":"2022","unstructured":"Shinotsuka, N. & Denk, F. Fibroblasts: the neglected cell type in peripheral sensitisation and chronic pain? A review based on a systematic search of the literature. BMJ Open Sci. 6, e100235 (2022).","journal-title":"BMJ Open Sci."},{"key":"777_CR274","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.1073\/pnas.1913444117","volume":"117","author":"P Singhmar","year":"2020","unstructured":"Singhmar, P. et al. The fibroblast-derived protein PI16 controls neuropathic pain. Proc. Natl Acad. Sci. USA 117, 5463\u20135471 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"777_CR275","doi-asserted-by":"publisher","DOI":"10.1097\/PR9.0000000000000873","volume":"6","author":"CEA Silva","year":"2021","unstructured":"Silva, C. E. A., Guimaraes, R. M. & Cunha, T. M. Sensory neuron-associated macrophages as novel modulators of neuropathic pain. Pain Rep. 6, e873 (2021).","journal-title":"Pain Rep."},{"key":"777_CR276","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13839-2","volume":"11","author":"X Yu","year":"2020","unstructured":"Yu, X. et al. Dorsal root ganglion macrophages contribute to both the initiation and persistence of neuropathic pain. Nat. Commun. 11, 264 (2020).","journal-title":"Nat. Commun."},{"key":"777_CR277","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02454-6","volume":"19","author":"Z Msheik","year":"2022","unstructured":"Msheik, Z., El Massry, M., Rovini, A., Billet, F. & Desmouliere, A. The macrophage: a key player in the pathophysiology of peripheral neuropathies. J. Neuroinflammation 19, 97 (2022).","journal-title":"J. Neuroinflammation"},{"key":"777_CR278","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/nrn.2018.2","volume":"19","author":"K Inoue","year":"2018","unstructured":"Inoue, K. & Tsuda, M. Microglia in neuropathic pain: cellular and molecular mechanisms and therapeutic potential. Nat. Rev. Neurosci. 19, 138\u2013152 (2018).","journal-title":"Nat. Rev. Neurosci."},{"key":"777_CR279","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/nature01786","volume":"424","author":"M Tsuda","year":"2003","unstructured":"Tsuda, M. et al. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424, 778\u2013783 (2003).","journal-title":"Nature"},{"key":"777_CR280","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nn.3599","volume":"17","author":"O Butovsky","year":"2014","unstructured":"Butovsky, O. et al. Identification of a unique TGF-\u03b2-dependent molecular and functional signature in microglia. Nat. Neurosci. 17, 131\u2013143 (2014).","journal-title":"Nat. Neurosci."},{"key":"777_CR281","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1126\/science.abl6773","volume":"377","author":"S Tansley","year":"2022","unstructured":"Tansley, S. et al. Microglia-mediated degradation of perineuronal nets promotes pain. Science 377, 80\u201386 (2022).","journal-title":"Science"},{"key":"777_CR282","doi-asserted-by":"publisher","first-page":"12603","DOI":"10.1074\/jbc.M115.636506","volume":"290","author":"Y Kobayashi","year":"2015","unstructured":"Kobayashi, Y. et al. Macrophage-T cell interactions mediate neuropathic pain through the glucocorticoid-induced tumor necrosis factor ligand system. J. Biol. Chem. 290, 12603\u201312613 (2015).","journal-title":"J. Biol. Chem."},{"key":"777_CR283","first-page":"003","volume":"2014","author":"K Draleau","year":"2014","unstructured":"Draleau, K. et al. Phenotypic identification of spinal cord-infiltrating CD4+ T Lymphocytes in a murine model of neuropathic pain. J. Pain Relief 2014, 003 (2014).","journal-title":"J. Pain Relief"},{"key":"777_CR284","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1472-8206.2009.00801.x","volume":"25","author":"AS Jaggi","year":"2011","unstructured":"Jaggi, A. S., Jain, V. & Singh, N. Animal models of neuropathic pain. Fundam. Clin. Pharmacol. 25, 1\u201328 (2011).","journal-title":"Fundam. Clin. Pharmacol."},{"key":"777_CR285","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1172\/JCI97943","volume":"128","author":"CN Serhan","year":"2018","unstructured":"Serhan, C. N. & Levy, B. D. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. J. Clin. Invest. 128, 2657\u20132669 (2018).","journal-title":"J. Clin. Invest."},{"key":"777_CR286","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.neuron.2018.11.009","volume":"100","author":"G Chen","year":"2018","unstructured":"Chen, G., Zhang, Y. Q., Qadri, Y. J., Serhan, C. N. & Ji, R. R. Microglia in pain: detrimental and protective roles in pathogenesis and resolution of pain. Neuron 100, 1292\u20131311 (2018).","journal-title":"Neuron"},{"key":"777_CR287","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.smim.2015.03.004","volume":"27","author":"CN Serhan","year":"2015","unstructured":"Serhan, C. N., Chiang, N. & Dalli, J. The resolution code of acute inflammation: novel pro-resolving lipid mediators in resolution. Semin. Immunol. 27, 200\u2013215 (2015).","journal-title":"Semin. Immunol."},{"key":"777_CR288","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.plefa.2005.05.002","volume":"73","author":"CN Serhan","year":"2005","unstructured":"Serhan, C. N. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. Prostaglandins Leukot. Essent. Fat. Acids 73, 141\u2013162 (2005).","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"777_CR289","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nri3362","volume":"13","author":"CD Buckley","year":"2013","unstructured":"Buckley, C. D., Gilroy, D. W., Serhan, C. N., Stockinger, B. & Tak, P. P. The resolution of inflammation. Nat. Rev. Immunol. 13, 59\u201366 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"777_CR290","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1096\/fj.06-7227rev","volume":"21","author":"CN Serhan","year":"2007","unstructured":"Serhan, C. N. et al. Resolution of inflammation: state of the art, definitions and terms. FASEB J. 21, 325\u2013332 (2007).","journal-title":"FASEB J."},{"key":"777_CR291","doi-asserted-by":"publisher","first-page":"108997","DOI":"10.1016\/j.jneumeth.2020.108997","volume":"348","author":"C Abboud","year":"2021","unstructured":"Abboud, C. et al. Animal models of pain: diversity and benefits. J. Neurosci. Methods 348, 108997 (2021).","journal-title":"J. Neurosci. Methods"},{"key":"777_CR292","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3109\/00207454.2014.922559","volume":"125","author":"SR Challa","year":"2015","unstructured":"Challa, S. R. Surgical animal models of neuropathic pain: pros and cons. Int. J. Neurosci. 125, 170\u2013174 (2015).","journal-title":"Int. J. Neurosci."},{"key":"777_CR293","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10787-013-0195-3","volume":"22","author":"N Khan","year":"2014","unstructured":"Khan, N. & Smith, M. T. Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models. Inflammopharmacology 22, 1\u201322 (2014).","journal-title":"Inflammopharmacology"},{"key":"777_CR294","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.2147\/JPR.S333270","volume":"14","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Animal models of complex regional pain syndrome type I. J. Pain Res. 14, 3711\u20133721 (2021).","journal-title":"J. Pain Res."},{"key":"777_CR295","doi-asserted-by":"publisher","first-page":"793745","DOI":"10.3389\/fneur.2021.793745","volume":"12","author":"E Mirabelli","year":"2021","unstructured":"Mirabelli, E. & Elkabes, S. Neuropathic pain in multiple sclerosis and its animal models: focus on mechanisms, knowledge gaps and future directions. Front. Neurol. 12, 793745 (2021).","journal-title":"Front. Neurol."},{"key":"777_CR296","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1100\/tsw.2008.33","volume":"8","author":"J Yanow","year":"2008","unstructured":"Yanow, J., Pappagallo, M. & Pillai, L. Complex regional pain syndrome (CRPS\/RSD) and neuropathic pain: role of intravenous bisphosphonates as analgesics. Sci. World J. 8, 229\u2013236 (2008).","journal-title":"Sci. World J."},{"key":"777_CR297","doi-asserted-by":"publisher","first-page":"102030","DOI":"10.1016\/j.pneurobio.2021.102030","volume":"201","author":"R Bouali-Benazzouz","year":"2021","unstructured":"Bouali-Benazzouz, R., Landry, M., Benazzouz, A. & Fossat, P. Neuropathic pain modeling: focus on synaptic and ion channel mechanisms. Prog. Neurobiol. 201, 102030 (2021).","journal-title":"Prog. Neurobiol."},{"key":"777_CR298","doi-asserted-by":"publisher","first-page":"107959","DOI":"10.1016\/j.pharmthera.2021.107959","volume":"230","author":"ES Brum","year":"2022","unstructured":"Brum, E. S., Becker, G., Fialho, M. F. P. & Oliveira, S. M. Animal models of fibromyalgia: what is the best choice? Pharmacol. Ther. 230, 107959 (2022).","journal-title":"Pharmacol. Ther."},{"key":"777_CR299","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00540-018-2579-4","volume":"33","author":"M Matsuda","year":"2019","unstructured":"Matsuda, M., Huh, Y. & Ji, R. R. Roles of inflammation, neurogenic inflammation, and neuroinflammation in pain. J. Anesth. 33, 131\u2013139 (2019).","journal-title":"J. Anesth."},{"key":"777_CR300","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","volume":"139","author":"AI Basbaum","year":"2009","unstructured":"Basbaum, A. I., Bautista, D. M., Scherrer, G. & Julius, D. Cellular and molecular mechanisms of pain. Cell 139, 267\u2013284 (2009).","journal-title":"Cell"}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41582-023-00777-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-023-00777-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-023-00777-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T09:09:42Z","timestamp":1677661782000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41582-023-00777-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":300,"alternative-id":["777"],"URL":"https:\/\/doi.org\/10.1038\/s41582-023-00777-3","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,1]]},"assertion":[{"value":"19 January 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}